<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0035">
    <title>19 Specimen Collection, Transport, and Processing: Bacteriology*</title>
    <sect1 id="ch0035s0001">
      <title>19 Specimen Collection, Transport, and Processing: Bacteriology*</title>
      <anchor id="ch0035s0001a0001"/>
      <anchor id="ch0035s0001a0002"/>
      <anchor id="ch0035s0001a0003"/>
      <para role="chapterAuthor"><phrase role="center">ERIN M<phrase role="small">C</phrase>ELVANIA AND KAMALJIT SINGH</phrase>
      </para>
      <para id="ch0035s0001p0001">The clinical microbiology laboratory is responsible for providing guidance on how to select, collect, label, and transport specimens for processing in the laboratory. This preanalytical phase of testing is critical for accurate laboratory resulting. It ensures the proper utilization of laboratory tests and the generation of results that are clinically significant and leads to improved patient outcomes. An improperly collected specimen can decrease the sensitivity of pathogen detection or introduce colonizing bacteria surrounding the site of infection, which complicates the laboratory workup of cultures and may result in unnecessary or inappropriate antimicrobial therapy. Such unnecessary therapy may in turn result in increased length of stay, additional costs, and potentially significant drug side effects (<link linkend="ch0035s0035s0001li0001">1</link>).</para>
      <para id="ch0035s0001p0002">Microbiologists must help health care providers to choose, collect, and transport the specimen in a manner that optimizes the laboratory’s diagnostic testing. To ensure high-quality results, microbiology laboratories should have clear procedures and policies on specimen acceptability and a system for rejecting inappropriate or insufficient specimens. One study showed that as many as 50% of inpatient laboratory tests ordered were inappropriate and not useful (<link linkend="ch0035s0035s0001li0002">2</link>). Therefore, clinical microbiology laboratories must develop and enforce specimen management policies that promote careful specimen collection and processing and must be prepared to educate health care providers who try to override such policies. Examples include the testing of formed stool for <emphasis>Clostridioides</emphasis> (formerly <emphasis>Clostridium</emphasis>) <emphasis>difficile</emphasis> toxin and the collection of swab specimens when tissue or fluid could be obtained. More detailed information about sample handling and collection can be found in the <emphasis>Clinical Microbiology Procedures Handbook</emphasis> (<link linkend="ch0035s0035s0001li0003">3</link>), and the Infectious Diseases Society of America (IDSA) and American Society for Microbiology (ASM) guidelines (<link linkend="ch0035s0035s0001li0004">4</link>).</para>
      <sect2 id="ch0035s0001s0001">
        <title>GENERAL PRINCIPLES OF SPECIMEN COLLECTION AND TRANSPORT</title>
        <anchor id="ch0035s0001s0001a0001"/>
        <anchor id="ch0035s0001s0001a0002"/>
        <para id="ch0035s0001s0001p0001">The preanalytical phase of microbial diagnosis involves (i) the collection of material from the site of suspected infection, (ii) proper timing for collection of specimens (preferably before the administration of antibiotics), (iii) optimal volume or quantity of specimen, (iv) use of appropriate collection devices and transport media, (v) proper labeling and maintenance of transport conditions, and (vi) a screening system to ensure that the specimen is acceptable for processing. General specimen selection and collection guidelines include proper labeling of the sample to include two patient identifiers, the source of the sample, and information on who collected the sample and at what time collection occurred.<anchor id="ch0035s0001s0001a0003"/><link linkend="ch0035s0003a0011">Table 1</link> summarizes collection and transport recommendations for routine bacteriology.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0035s0002">
      <title>The Specimen Must Represent the Infected Site</title>
      <anchor id="ch0035s0002a0001"/>
      <anchor id="ch0035s0002a0002"/>
      <para id="ch0035s0002p0001">The optimal specimen to be collected for laboratory diagnosis is based on the site of the infection and the nature of the suspected bacterium.<anchor id="ch0035s0002a0003"/><link linkend="ch0035s0003a0019">Table 2</link> lists anatomic sites and corresponding appropriate and inappropriate clinical specimens (<link linkend="ch0035s0035s0001li0005">5</link>).</para>
    </sect1>
    <sect1 id="ch0035s0003">
      <title>Aspirates</title>
      <anchor id="ch0035s0003a0001"/>
      <anchor id="ch0035s0003a0002"/>
      <para id="ch0035s0003p0001">For abscess contents, body fluids, and other fluid collections below the skin, aspirates obtained through disinfected intact skin are preferred. The skin should be thoroughly cleaned with chlorhexidine-alcohol or iodine-alcohol and allowed to completely dry before the needle is inserted. If anaerobes are being considered, the transport container must be free of air. Anaerobic transport vials with a nitrogen atmosphere above a gel containing oxygen-scavenging components are commercially available.</para>
      <para id="ch0035s0003p0002">Normally sterile fluids, such as pleural, synovial, peritoneal, and pericardial fluids, should be sent to the laboratory in a capped syringe with the needle removed or placed in a sterile leak-proof cup for Gram staining and inoculation to culture media. Fluids should be concentrated using a Cytospin prior to Gram staining unless they are bloody or thick. If sufficient volume is received, recovery of clinically significant microorganisms can be improved by injecting up to 10 ml of sterile fluid (the inoculum volume should follow the manufacturer’s guidelines for the blood culture system) into an aerobic blood culture bottle (<link linkend="ch0035s0035s0001li0006">6</link>).</para>
      <anchor id="ch0035s0003a0003"/>
      <beginpage pagenum="360"/>
      <anchor id="ch0035s0003a0004"/>
      <beginpage pagenum="361"/>
      <anchor id="ch0035s0003a0005"/>
      <beginpage pagenum="362"/>
      <anchor id="ch0035s0003a0006"/>
      <beginpage pagenum="363"/>
      <anchor id="ch0035s0003a0007"/>
      <beginpage pagenum="364"/>
      <anchor id="ch0035s0003a0008"/>
      <beginpage pagenum="365"/>
      <anchor id="ch0035s0003a0009"/>
      <beginpage pagenum="366"/>
      <anchor id="ch0035s0003a0010"/>
      <beginpage pagenum="367"/>
      <table id="ch0035s0003t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0003a0011"/><link linkend="ch0035s0001s0001a0003">TABLE 1</link></phrase></emphasis> Collection, transport, and storage guidelines for microbiological laboratory diagnostic studies<superscript><link linkend="ch0035s0003a0016"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0003a0012"/>
</title>
        
        <tgroup cols="7">
          <tbody>
            <row>
              <entry><phrase role="center">Specimen type</phrase>
              </entry>
              <entry><phrase role="center">Collection guideline(s)</phrase>
              </entry>
              <entry><phrase role="center">Transport<superscript><link linkend="ch0035s0003a0017"><emphasis>b</emphasis></link></superscript> device and/or minimum vol</phrase>
                <anchor id="ch0035s0003a0013"/>
              </entry>
              <entry><phrase role="center">Transport time</phrase>
              </entry>
              <entry><phrase role="center">Storage time and temp</phrase>
              </entry>
              <entry><phrase role="center">Replica limits</phrase>
              </entry>
              <entry><phrase role="center">Comment(s)</phrase>
              </entry>
            </row>
            <row>
              <entry>Abscess</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>General</entry>
              <entry>Remove surface exudate by wiping with sterile saline or 70% alcohol.</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry>Tissue or aspirate is always superior to a swab specimen. If swabs must be used, use E-swab transport system or preserve material on wound swabs by placing in Stuart’s or Amies medium.</entry>
            </row>
            <row>
              <entry>Open</entry>
              <entry>Aspirate if possible or pass a swab deep into the lesion to firmly sample the lesion’s “fresh border.”</entry>
              <entry>Swab transport system</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day/source</entry>
              <entry>A sample of the base of the lesion and one of the abscess wall are most productive.</entry>
            </row>
            <row>
              <entry>Closed</entry>
              <entry>Aspirate abscess material with needle and syringe. Aseptically transfer all material into anaerobic transport device.</entry>
              <entry>Anaerobic transport system, ≥1 ml</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day/source</entry>
              <entry>Contamination with surface material will introduce colonizing bacteria. Capped syringe without needle can be used for transport.</entry>
            </row>
            <row>
              <entry>Blood</entry>
              <entry><para>Disinfect culture bottle; apply 70% isopropyl alcohol or chlorhexidine to rubber stoppers and wait 30 s.</para>
                <para id="ch0035s0003p0003">Disinfect venipuncture site.</para>
                <orderedlist>
                  <listitem id="ch0035s0003li0001">
                    <para>Cleanse site with 70% isopropyl or ethyl alcohol and allow to dry.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0002">
                    <para>Scrub site with 2% chlorhexidine-alcohol using a back-and-forth scrubbing motion for approximately 30 s. Alternatively, cleanse site with iodine tincture.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0003">
                    <para>Allow at least 30 seconds for the disinfectant to dry.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0004">
                    <para>Do not palpate vein at this point without sterile glove.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0005">
                    <para>Collect blood sample.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Blood culture bottles for bacteria; adult, 20 ml/set<superscript><link linkend="ch0035s0003a0018"><emphasis>c</emphasis></link></superscript><anchor id="ch0035s0003a0014"/> (higher vol is most productive); infant and child, 1–20 ml/set depending on weight of patient (see <anchor id="ch0035s0003a0015"/><link linkend="ch0035s0020a0003">Table 6</link>)</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤2 h, RT or per instructions</entry>
              <entry>Four sets in 24 h</entry>
              <entry><para>Acute febrile episode: two sets</para>
                <para><emphasis>
                    <link linkend="ch0035s0003a0018">c</link>
                  </emphasis>
                </para>
                <para>from separate sites, all within 10 min (before antimicrobials)</para>
                <para id="ch0035s0003p0004">Nonacute disease: antimicrobials will not be started or changed immediately; two to four sets from separate sites, all within 24 h at intervals no closer than 3 h (before antimicrobials)</para>
                <para id="ch0035s0003p0005">Endocarditis, acute: three sets from separate sites, at least 1 h apart, before antimicrobials if possible</para>
                <para id="ch0035s0003p0006">Fever of unknown origin: two to four sets from separate sites. If negative at 24–48 h, obtain two or three more sets.</para>
                <para id="ch0035s0003p0007">Pediatric: collect immediately; rarely necessary to document continuous bacteremia with hours between cultures.</para>
              </entry>
            </row>
            <row>
              <entry>Bone marrow aspirate</entry>
              <entry>Prepare puncture site as for surgical incision.</entry>
              <entry>Inoculate blood culture bottle or a 1.5-ml lysis-centrifugation tube.</entry>
              <entry>≤24 h, RT if in culture bottle or tube</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>Small volumes of bone marrow may be inoculated directly onto culture media. Routine bacterial culture of bone marrow is rarely useful.</entry>
            </row>
            <row>
              <entry>Catheter</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Intravenous</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0006">
                    <para>Cleanse the skin around the catheter site with alcohol.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0007">
                    <para>Aseptically remove catheter and clip 5 cm of distal tip directly into a sterile tube. Some elect to culture the 5-cm intracutaneous portion to evaluate for soft tissue infection.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0008">
                    <para>Transport immediately to microbiology laboratory to prevent drying.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile screw-cap tube or cup</entry>
              <entry>≤15 min, RT</entry>
              <entry>≤2 h, 4°C</entry>
              <entry>None</entry>
              <entry><para>Controversial whether culture of catheter tips is clinically relevant</para>
                <para id="ch0035s0003p0008">Acceptable intravenous catheters for semiquantitative culture (Maki roll method): central, CVP, Hickman, Broviac, peripheral, arterial, umbilical, hyperalimentation, Swan-Ganz</para>
              </entry>
            </row>
            <row>
              <entry>Foley</entry>
              <entry>Do not culture, since growth represents distal urethral flora.</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry>Not acceptable for culture</entry>
            </row>
            <row>
              <entry>CSF</entry>
              <entry>Disinfect site prior to specimen collection.</entry>
              <entry><para>Sterile screw-cap tubes</para>
                <para id="ch0035s0003p0009">Minimum amt required: bacteria, ≥1 ml; acid fast, ≥5 ml</para>
              </entry>
              <entry>Bacteria: never refrigerate; ≤15 min, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>None</entry>
              <entry><para>If only one tube of CSF is collected, it should be submitted to microbiology first; otherwise, submit tube 2 to microbiology.</para>
                <para id="ch0035s0003p0010">Aspirate of brain abscess or a biopsy may be necessary to detect anaerobic bacteria or parasites.</para>
              </entry>
            </row>
            <row>
              <entry>Decubitus ulcer</entry>
              <entry><para>A swab is not the specimen of choice.</para>
                <orderedlist>
                  <listitem id="ch0035s0003li0009">
                    <para>Cleanse surface with sterile saline.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0010">
                    <para>If a biopsy sample is not available, aspirate inflammatory material from the base of the ulcer.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile tube/container (aerobic) or anaerobic system (for tissue)</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day/source</entry>
              <entry>A tissue biopsy sample or needle aspirate is the specimen of choice. Swab specimens from this source should be rejected.</entry>
            </row>
            <row>
              <entry>Ear</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Inner</entry>
              <entry><para>Tympanocentesis reserved for complicated, recurrent, or chronic persistent otitis media.</para>
                <orderedlist>
                  <listitem id="ch0035s0003li0011">
                    <para>For intact ear drum, clean ear canal with soap solution and collect fluid via syringe aspiration technique (tympanocentesis).</para>
                  </listitem>
                  <listitem id="ch0035s0003li0012">
                    <para>For ruptured ear drum, collect fluid on flexible shaft swab via an auditory speculum (aerobic culture only).</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile tube system or anaerobic transport system</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day/source</entry>
              <entry/>
            </row>
            <row>
              <entry>Outer</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0013">
                    <para>Use a moistened swab to remove any debris or crust from the ear canal.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0014">
                    <para>Obtain a sample by firmly rotating swab in the outer canal.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Wound swab or E-swab transport system</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, 4°C</entry>
              <entry>1/day/source</entry>
              <entry>For otitis externa, vigorous swabbing is required, since surface swabbing may miss streptococcal cellulitis.</entry>
            </row>
            <row>
              <entry>Eye</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Conjunctiva</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0015">
                    <para>Sample both eyes with separate swabs (premoistened with sterile saline) by rolling over each conjunctiva.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0016">
                    <para>Medium may be inoculated at time of collection.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0017">
                    <para>Smear may be prepared at time of collection. Roll swab over 1- to 2-cm area of slide.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry><para>Direct culture inoculation: BAP and CHOC</para>
                <para id="ch0035s0003p0011">Laboratory inoculation: E-swab transport system</para>
              </entry>
              <entry><para>Plates: ≤15 min, RT</para>
                <para id="ch0035s0003p0012">Swabs: ≤2 h, RT</para>
              </entry>
              <entry>≤24 h, RT</entry>
              <entry>None</entry>
              <entry>If possible, sample both conjunctiva even if only one is infected, to determine indigenous microbiota. The uninfected eye can serve as a control with which to compare the agents isolated from the infected eye. If cost prohibits this approach, rely on the Gram stain to assist in interpretation of culture.</entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <table id="ch0035s0003t0002"><title>Table 2 (continued)</title>
        
        <tgroup cols="7">
          <tbody>
            <row>
              <entry>Corneal scrapings</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0018">
                    <para>Specimen is collected by an ophthalmologist.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0019">
                    <para>Using a sterile spatula, scrape ulcers or lesions and inoculate scraping directly onto medium.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0020">
                    <para>Prepare two smears by rubbing material from spatula onto 1- to 2-cm area of slide.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Direct culture inoculations: BHI with 10% sheep blood, CHOC, and inhibitory mold agar</entry>
              <entry>≤15 min, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>None</entry>
              <entry>If conjunctival specimen is collected, do so before anesthetic application, which may inhibit some bacteria. Corneal scrapings are obtained after anesthesia. Scrapings for virus isolation and ameba detection should be submitted in a sterile container.</entry>
            </row>
            <row>
              <entry>Vitreous fluid aspirates</entry>
              <entry>Prepare eye for needle aspiration of fluid.</entry>
              <entry>Sterile screw-cap tube or direct inoculation of small amount of fluid onto media</entry>
              <entry>≤15 min, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>Include fungal media. Anesthetics may be inhibitory to some etiologic agents.</entry>
            </row>
            <row>
              <entry>Feces</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Routine culture</entry>
              <entry>Transfer liquid or soft specimen directly into a clean, dry container. Transport to microbiology laboratory within 1 h of collection or transfer to Cary-Blair holding medium.</entry>
              <entry>Clean, leakproof, wide-mouthed container, or Cary-Blair holding medium (≥2 g)</entry>
              <entry><para>Unpreserved: ≤1 h, RT</para>
                <para id="ch0035s0003p0013">Holding medium: ≤24 h, RT</para>
              </entry>
              <entry><para>≤24 h, 4°C</para>
                <para id="ch0035s0003p0014">≤48 h, RT or 4°C</para>
              </entry>
              <entry>1/day</entry>
              <entry>Do not perform routine stool cultures for patients whose length of hospital stay is ≥3 days without consultation with physician. Tests for<emphasis>C. difficile</emphasis> should be considered for these patients.</entry>
            </row>
            <row>
              <entry><emphasis>C. difficile</emphasis>
              </entry>
              <entry>Transfer liquid or soft stool directly into a clean, dry container.</entry>
              <entry>Sterile, leakproof, wide-mouthed container, ≥5 ml</entry>
              <entry><para>≤1 h, RT</para>
                <para id="ch0035s0003p0015">1–24 h, 4°C</para>
              </entry>
              <entry>2 days, 4°C for culture or NAAT</entry>
              <entry/>
              <entry><para>Patients should be passing ≥3 liquid or soft stools per 24 h and not have received laxatives.</para>
                <para id="ch0035s0003p0016">Testing of formed or hard stool is not recommended.</para>
              </entry>
            </row>
            <row>
              <entry><emphasis>E. coli</emphasis> (O157:H7 and other Shiga toxin-producing serotypes)</entry>
              <entry>Pass liquid or bloody stool into a clean, dry container.</entry>
              <entry>Sterile, leakproof, wide-mouthed container, or Cary-Blair holding medium (≥2 g)</entry>
              <entry><para>Unpreserved: ≤1 h, RT</para>
                <para id="ch0035s0003p0017">Swab transport system: ≤24 h, RT or 4°C</para>
              </entry>
              <entry><para>≤24 h, 4°C</para>
                <para id="ch0035s0003p0018">≤24 h, RT</para>
              </entry>
              <entry>1/day</entry>
              <entry>Bloody or liquid stools collected within 6 days of onset from patients with abdominal cramps have the highest yield.</entry>
            </row>
            <row>
              <entry>Rectal swab</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0021">
                    <para>Carefully insert a swab approx 1–1.5 in. beyond the anal sphincter.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0022">
                    <para>Gently rotate the swab to sample the anal crypts.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0023">
                    <para>Feces should be visible on the swab for detection of diarrheal pathogens.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry/>
            </row>
            <row>
              <entry>Fistulas</entry>
              <entry>See “Abscess,” above</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Fluids: abdominal, amniotic, ascites, bile, joint, pericardial, peritoneal, pleural, synovial</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0024">
                    <para>Disinfect overlying skin with chlorhexidine-alcohol.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0025">
                    <para>Obtain specimen via percutaneous needle aspiration or surgery.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0026">
                    <para>Always submit as much fluid as possible; never submit a swab dipped in fluid.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Anaerobic transport system, sterile screw-cap tube, capped syringe with needle removed, or blood culture bottle for bacteria. Transport immediately to laboratory.</entry>
              <entry>≤15 min, RT</entry>
              <entry><para>≤24 h, RT</para>
                <para id="ch0035s0003p0019">Pericardial fluid and fluids for fungal cultures, ≤24 h, 4°C</para>
              </entry>
              <entry>None</entry>
              <entry>Amniotic and culdocentesis fluids should be transported in an anaerobic system and need not be centrifuged prior to Gram staining. Other fluids are best examined by Gram staining of a cytocentrifuged preparation. If volume permits, inclusion of one inoculated aerobic blood culture bottle is highly recommended.</entry>
            </row>
            <row>
              <entry>Gangrenous tissue</entry>
              <entry>See “Abscess,” above</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry>Discourage sampling of surface or superficial tissue. Tissue biopsy samples or aspirates should be collected.</entry>
            </row>
            <row>
              <entry>Gastric</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Wash or lavage for mycobacteria</entry>
              <entry><para>Collect in early morning before patients eat and while they are still in bed.</para>
                <orderedlist>
                  <listitem id="ch0035s0003li0027">
                    <para>Introduce a nasogastric tube into the stomach.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0028">
                    <para>Perform lavage with 25–50 ml of chilled sterile, distilled water.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0029">
                    <para>Recover sample and place in a leak-proof, sterile container.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile, leakproof container</entry>
              <entry>≤15 min, RT, or neutralize within 1 h of collection</entry>
              <entry>≤24 h, 4°C</entry>
              <entry>1/day</entry>
              <entry>The specimen must be processed promptly, since mycobacteria die rapidly in gastric washings. Neutralize when holding for ≥1 h with sodium bicarbonate.</entry>
            </row>
            <row>
              <entry>Biopsy sample for<emphasis>Helicobacter pylori</emphasis></entry>
              <entry>Collected by gastroenterologist during endoscopy</entry>
              <entry>Sterile tube with transport medium</entry>
              <entry>≤1 h, RT</entry>
              <entry>≤24 h, 4°C</entry>
              <entry>None</entry>
              <entry>Culture may be needed for antimicrobial susceptibility testing.</entry>
            </row>
            <row>
              <entry>Genital: female</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Amniotic fluid</entry>
              <entry>Aspirate via amniocentesis, or collect during cesarean delivery.</entry>
              <entry>Anaerobic transport system, ≥1 ml</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>None</entry>
              <entry>Swabbing or aspiration of vaginal secretions is not acceptable because of the potential for contamination with commensal vaginal microbiota.</entry>
            </row>
            <row>
              <entry>Bartholin gland secretions</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0030">
                    <para>Disinfect skin with iodine preparation.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0031">
                    <para>Aspirate fluid from ducts.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Anaerobic transport system, ≥1 ml</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry/>
            </row>
            <row>
              <entry>Cervical secretions</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0032">
                    <para>Visualize the cervix using a speculum without lubricant.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0033">
                    <para>Remove mucus and secretions from the cervical os with swab and discard the swab.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0034">
                    <para>Firmly yet gently sample the endocervical canal with a new sterile swab.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>See text for collection and transport needed for<emphasis>C. trachoma</emphasis><emphasis>tis</emphasis> and <emphasis>N. gonorrhoeae</emphasis>.</entry>
            </row>
            <row>
              <entry>Cul-de-sac fluid</entry>
              <entry>Submit aspirate or fluid.</entry>
              <entry>Anaerobic transport system, ≥1 ml</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry/>
            </row>
          </tbody>
        </tgroup>
      </table>
      <table id="ch0035s0003t0003"><title>Table 3 (continued)</title>
        
        <tgroup cols="7">
          <tbody>
            <row>
              <entry>Endometrial tissue and secretions</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0035">
                    <para>Collect transcervical aspirate via a telescoping catheter.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0036">
                    <para>Transfer entire amount to anaerobic transport system.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Anaerobic transport system, ≥1 ml</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry/>
            </row>
            <row>
              <entry>Products of conception</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0037">
                    <para>Submit a portion of tissue in a sterile container.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0038">
                    <para>If obtained by cesarean delivery, immediately transfer to an anaerobic transport system.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile tube or anaerobic transport system</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>Do not process lochia, culture of which may give misleading results.</entry>
            </row>
            <row>
              <entry>Urethral secretions, female</entry>
              <entry><para>Collect at least 1 h after patient has urinated.</para>
                <orderedlist>
                  <listitem id="ch0035s0003li0039">
                    <para>Remove old exudate from the urethral orifice.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0040">
                    <para>Collect discharge material on a swab by massaging the urethra against the pubic symphysis through the vagina.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>If no discharge can be obtained, wash the periurethral area with povidone-iodine soap and rinse with water. Insert a small swab 2–4 cm into the urethra, rotate swab, and leave swab in place for at least 2 s to facilitate absorption.</entry>
            </row>
            <row>
              <entry>Vaginal secretions</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0041">
                    <para>Wipe away old secretions/discharge.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0042">
                    <para>Obtain secretions from the mucosal membrane of the vaginal wall with a sterile swab or pipette.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0043">
                    <para>If a smear is also needed, use a second swab.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry><para>For IUD, place entire device into a sterile container and submit at RT.</para>
                <para id="ch0035s0003p0020">Gram staining or molecular testing, not culture, is recommended for the diagnosis of BV.</para>
                <para id="ch0035s0003p0021">For detection of group B streptococcal colonization, also add rectal swab.</para>
                <para id="ch0035s0003p0022">Vaginal swab for NAAT is recommended for diagnosis of<emphasis>N. gonorrhoeae</emphasis> and <emphasis>C. trachomatis</emphasis></para>
              </entry>
            </row>
            <row>
              <entry>Genital: female or male lesion</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0044">
                    <para>Clean with sterile saline and remove lesion’s surface with a sterile scalped blade.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0045">
                    <para>Allow transudate to accumulate.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0046">
                    <para>While pressing the base of the lesion, firmly rub base with a sterile swab to collect fluid.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry/>
            </row>
            <row>
              <entry>Genital: male</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Prostate</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0047">
                    <para>Cleanse the urethral meatus with soap and water.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0048">
                    <para>Massage the prostate through the rectum.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0049">
                    <para>Collect fluid expressed from the urethra on a sterile swab.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport or sterile tube for ≥1 ml of specimen</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry><para>Pathogens in prostatic secretions may be identified by quantitative culture of urine before and after massage.</para>
                <para id="ch0035s0003p0023">Ejaculate may also be cultured.</para>
              </entry>
            </row>
            <row>
              <entry>Urethra</entry>
              <entry>Insert a small swab 2–4 cm into the urethral lumen, rotate swab, and leave it in place for at least 2 s to facilitate absorption.</entry>
              <entry>Swab transport</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>Male urethral swab for NAAT is recommended for diagnosis of<emphasis>N. gonorrhoeae</emphasis> and <emphasis>C. trachomatis</emphasis></entry>
            </row>
            <row>
              <entry>Pilonidal cyst</entry>
              <entry>See “Abscess,” above</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Respiratory, lower</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Bronchoalveolar lavage, brush, or wash; endotracheal aspirate</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0050">
                    <para>Collect washing or aspirate in a sputum trap.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0051">
                    <para>Place brush in sterile container with 1 ml of saline.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile container, ≥1 ml</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, 4°C</entry>
              <entry>1/day</entry>
              <entry>A total of 40–80 ml of fluid is needed for quantitative analysis. For quantitative analysis of brushings, place brush in 1.0 ml of saline.</entry>
            </row>
            <row>
              <entry>Sputum, expectorated</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0052">
                    <para>Have patient rinse or gargle with water to remove excess oral microbiota.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0053">
                    <para>Instruct patient to cough deeply to produce a lower respiratory specimen (not postnasal fluid).</para>
                  </listitem>
                  <listitem id="ch0035s0003li0054">
                    <para>Collect in a sterile container.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry><para>Sterile container, ≥1 ml</para>
                <para id="ch0035s0003p0024">Minimum amt: bacteria, ≥1 ml</para>
              </entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, 4°C</entry>
              <entry>1/day</entry>
              <entry>For pediatric patients unable to produce a sputum specimen, a respiratory therapist should collect a specimen via suction.</entry>
            </row>
            <row>
              <entry>Sputum, induced</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0055">
                    <para>Have patient rinse mouth with water after brushing gums and tongue.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0056">
                    <para>With the aid of a nebulizer, have patients inhale ~25 ml of 3–10% sterile saline.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0057">
                    <para>Collect in a sterile container.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile container, ≥1 ml</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>Same as above for sputum, expectorated</entry>
            </row>
            <row>
              <entry>Respiratory, upper</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Oral</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0058">
                    <para>Remove oral secretions and debris from the surface of the lesion with a swab. Discard this swab.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0059">
                    <para>Using a second swab, vigorously sample the lesion, avoiding any areas of normal tissue.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>Discourage sampling of superficial tissue for bacterial evaluation. Tissue biopsy specimens or needle aspirates are the specimens of choice.</entry>
            </row>
            <row>
              <entry>Nasal</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0060">
                    <para>Insert a swab approx 1–2 cm into the nares.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0061">
                    <para>Rotate the swab against the nasal mucosa.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>Anterior nose cultures are reserved for detecting staphylococcal carriers or for nasal lesions.</entry>
            </row>
            <row>
              <entry>Nasopharynx</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0062">
                    <para>Gently insert a small Dacron/nylon swab or nasopharyngeal flocked swab into the posterior nasopharynx via the nose.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0063">
                    <para>Rotate swab slowly for 5 s to absorb secretions.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Viral or universal transport medium.</entry>
              <entry><para>Plates: ≤15 min, RT</para>
                <para id="ch0035s0003p0025">Swabs: ≤2 h, RT</para>
              </entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry>Calcium alginate swabs should not be used for molecular testing.</entry>
            </row>
            <row>
              <entry>Throat or pharynx</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0064">
                    <para>Depress tongue with a tongue depressor.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0065">
                    <para>Sample the posterior pharynx, tonsils, and inflamed areas with a sterile swab.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Swab transport (dry swab with or without silica gel for<emphasis>S. pyogenes</emphasis> and <emphasis>C. diphtheriae</emphasis>)</entry>
              <entry>≤2 h, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>1/day</entry>
              <entry><para>Throat swab cultures are contraindicated in patients with epiglottitis.</para>
                <para id="ch0035s0003p0026">Swabs for<emphasis>N. gonorrhoeae</emphasis> should be placed in charcoal-containing or other specific transport medium and plated ≤12 h after collection</para>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <table id="ch0035s0003t0004"><title>Table 4 (continued)</title>
        
        <tgroup cols="7">
          <tbody>
            <row>
              <entry>Tissue</entry>
              <entry>Collected during surgery or cutaneous biopsy procedure</entry>
              <entry>Anaerobic transport system or sterile, screw-cap container. Add several drops of sterile saline to keep small pieces of tissue moist.</entry>
              <entry>≤15 min, RT</entry>
              <entry>≤24 h, RT</entry>
              <entry>None</entry>
              <entry><para>Always submit as much tissue as possible. If there is excess tissue, save a portion of surgical tissue at −70°C in case further studies are needed.</para>
                <para id="ch0035s0003p0027">Never submit a swab that has been rubbed over the surface of a tissue.</para>
                <para id="ch0035s0003p0028">For quantitative tissue culture from burn patients, a sample of 1 cm<superscript>3</superscript> is appropriate.</para>
              </entry>
            </row>
            <row>
              <entry>Urine</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Male and female, first void (for<emphasis>Chlamydia</emphasis> and <emphasis>N. gonorrhoeae</emphasis> NAAT)</entry>
              <entry/>
              <entry>Sterile tube or transport medium specified by NAAT manufacturer</entry>
              <entry>Unpreserved: ≤2 h, RT; ≤24 h, 4°C</entry>
              <entry>As specified by NAAT manufacturer</entry>
              <entry>1/infectious episode</entry>
              <entry>Do not collect ≥30 ml for NAAT.</entry>
            </row>
            <row>
              <entry>Female, midstream (for bacterial culture)</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0066">
                    <para>While holding the labia apart, begin voiding.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0067">
                    <para>After several milliliters has passed, collect a midstream portion without stopping the flow of urine.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0068">
                    <para>The midstream portion is used for bacterial culture.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile, wide-mouthed container, ≥1 ml, or urine transport tube with boric acid preservative</entry>
              <entry><para>Unpreserved: ≤1/2 h, RT</para>
                <para id="ch0035s0003p0029">Preserved: ≤24 h, RT</para>
              </entry>
              <entry>≤24 h, 4°C</entry>
              <entry>1/day</entry>
              <entry>Urine is toxic to cell lines and is therefore not the specimen of choice for chlamydial culture.</entry>
            </row>
            <row>
              <entry>Straight catheter</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0069">
                    <para>Thoroughly cleanse the urethral opening with soap and water.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0070">
                    <para>Rinse area with wet gauze pads.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0071">
                    <para>Aseptically, insert catheter into the bladder.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0072">
                    <para>After allowing ~15 ml to pass, collect urine to be submitted in a sterile container.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile, leakproof container or urine transport tube with boric acid preservative</entry>
              <entry><para>Unpreserved: ≤1/2 h, RT</para>
                <para id="ch0035s0003p0030">Preserved: ≤24 h, RT</para>
              </entry>
              <entry>≤24 h, 4°C</entry>
              <entry>1/day</entry>
              <entry>Catheterization may introduce urethral microbiota into the bladder and increase the risk of iatrogenic infection.</entry>
            </row>
            <row>
              <entry>Indwelling catheter</entry>
              <entry><orderedlist>
                  <listitem id="ch0035s0003li0073">
                    <para>Disinfect the catheter collection port with 70% alcohol. Clamp catheter below port and allow urine to collect in tubing for 10–20 min.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0074">
                    <para>Use needle and syringe to aseptically collect 5–10 ml of urine.</para>
                  </listitem>
                  <listitem id="ch0035s0003li0075">
                    <para>Transfer to a sterile tube or container.</para>
                  </listitem>
                </orderedlist>
              </entry>
              <entry>Sterile, leakproof container or urine transport tube with boric acid preservative</entry>
              <entry><para>Unpreserved: ≤1/2 h, RT</para>
                <para id="ch0035s0003p0031">Preserved: ≤24 h, RT</para>
              </entry>
              <entry>≤24 h, 4°C</entry>
              <entry>1/day</entry>
              <entry>Patients with indwelling catheters are asymptomatically colonized. Collect urine for culture only from symptomatic patients. The urine should be obtained from a freshly placed catheter.</entry>
            </row>
            <row>
              <entry>Wound</entry>
              <entry>See “Abscess,” above</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><link linkend="ch0035s0003a0012"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0003a0016"/>Abbreviations: BAP, blood agar plate; BHI, brain heart infusion; CHOC, chocolate agar; CVP, central venous pressure; EHEC, enterohemorrhagic <emphasis>E. coli</emphasis>; RT, room temperature.</para>
      <para role="table-footnote"><superscript><link linkend="ch0035s0003a0013"><emphasis>b</emphasis></link></superscript><anchor id="ch0035s0003a0017"/>All specimen containers are to be transported in leakproof plastic bags having a separate compartment for the requisition.</para>
      <para role="table-footnote"><superscript><link linkend="ch0035s0003a0014"><emphasis>c</emphasis></link></superscript><anchor id="ch0035s0003a0018"/>One set usually refers to one culture with both aerobic and anaerobic broths.</para>
      <table id="ch0035s0003t0005"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0003a0019"/><link linkend="ch0035s0002a0003">TABLE 2</link></phrase></emphasis> Selection of common clinical specimens for bacterial culture<superscript><link linkend="ch0035s0003a0021"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0003a0020"/>
</title>
        
        <tgroup cols="3">
          <tbody>
            <row>
              <entry><phrase role="center">Anatomic site</phrase>
              </entry>
              <entry><phrase role="center">Clinical specimen</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="center">Appropriate</phrase>
              </entry>
              <entry><phrase role="center">Inappropriate</phrase>
              </entry>
            </row>
            <row>
              <entry>Lower respiratory tract</entry>
              <entry>Freshly expectorated mucus with inflammatory cells (pus), sputum</entry>
              <entry>Saliva, oropharyngeal secretions, sinus drainage from nasopharynx</entry>
            </row>
            <row>
              <entry/>
              <entry>Bronchoalveolar lavage fluids</entry>
              <entry/>
            </row>
            <row>
              <entry/>
              <entry>Endotracheal aspirates</entry>
              <entry/>
            </row>
            <row>
              <entry>Sinus</entry>
              <entry>Secretions collected by direct sinus aspiration and washes, curettage, and biopsy material collected during endoscopy</entry>
              <entry>Nasal or nasopharyngeal swab, nasopharyngeal secretions, sputum, and saliva</entry>
            </row>
            <row>
              <entry>Urinary tract</entry>
              <entry>Midstream urine, urine collected by straight catheterization, suprapubic aspiration, cystoscopy, or other surgical procedure</entry>
              <entry>Urine from Foley catheter collection bag, bagged urine from infants</entry>
            </row>
            <row>
              <entry>Superficial wound</entry>
              <entry>Aspirations of pus or local irrigation fluid (nonbacteriostatic saline), swab of purulence originating from beneath the dermis</entry>
              <entry>Swab of surface material or specimen contaminated with surface material, irrigation with solution containing preservative</entry>
            </row>
            <row>
              <entry>Deep wound</entry>
              <entry>Purulence, necrosis, or tissue from deep subcutaneous site</entry>
              <entry>Specimen contaminated with surface material</entry>
            </row>
            <row>
              <entry>Gastrointestinal tract</entry>
              <entry>Freshly passed stool, or feces collected during endoscopy; FecalSwab in Cary-Blair medium (Copan)</entry>
              <entry>Rectal swab</entry>
            </row>
            <row>
              <entry>Venous blood</entry>
              <entry>Two to four blood specimens collected from separate venipunctures before initiation of antibiotics, each containing ~20 ml of blood for patients ≥90 lb (see<link linkend="ch0035s0020a0003">Table 6</link> for pediatric volumes)</entry>
              <entry>Clotted blood</entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><link linkend="ch0035s0003a0020"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0003a0021"/>Modified from reference <link linkend="ch0035s0035s0001li0006">6</link> with permission.</para>
    </sect1>
    <sect1 id="ch0035s0004">
      <title>Hardware and Prosthetic Devices</title>
      <anchor id="ch0035s0004a0001"/>
      <anchor id="ch0035s0004a0002"/>
      <para id="ch0035s0004p0001">When prosthetic joint infection is suspected, at least 3 and optimally 5 or 6 periprosthetic tissue samples should be obtained for aerobic and anaerobic culture (<link linkend="ch0035s0035s0001li0007">7</link>, <link linkend="ch0035s0035s0001li0008">8</link>). Isolation of the same species from at least 2 tissue samples from the infected site can help diagnose infection and differentiate contamination from true infection (<link linkend="ch0035s0035s0001li0008">8</link>). However, prostheses may acquire a biofilm that promotes persistent infection that is difficult to diagnose by culture of joint fluid or tissue. Sonication of the prosthesis in a volume of liquid has been shown to increase sensitivity of detection of organisms over standard tissue culture (<link linkend="ch0035s0035s0001li0009">9</link>). Sonication of implantable cardiac devices, such as pacemakers and implantable cardioverter defibrillators, has also been shown to improve sensitivity for detection of infection (<link linkend="ch0035s0035s0001li0010">10</link>). In addition, sonication of other hardware, including spinal implants, has been described (<link linkend="ch0035s0035s0001li0011">11</link>). For laboratories that lack specialized equipment for sonication of devices, a reasonable alternative is to add sterile saline to the device and vortex, followed by direct inoculation of the saline to culture medium. However, laboratories should continue to encourage providers to collect periprosthetic tissue for optimal diagnosis of infection associated with devices, including implantable cardiac devices (<link linkend="ch0035s0035s0001li0012">12</link>).</para>
    </sect1>
    <sect1 id="ch0035s0005">
      <title>Sputum</title>
      <anchor id="ch0035s0005a0001"/>
      <anchor id="ch0035s0005a0002"/>
      <para id="ch0035s0005p0001">Expectorated sputum is the best noninvasive sample for diagnosis of pneumonia. The quality of sputa from patients other than those with cystic fibrosis should be evaluated microscopically for the presence of squamous epithelial cells (SECs), inflammatory cells, and bacteria (<link linkend="ch0035s0035s0001li0013">13</link>, <link linkend="ch0035s0035s0001li0014">14</link>). To collect a high-quality sputum specimen, the patient should sit up, rinse out their mouth with water, and bring up a deep cough from the lungs. Sometimes mild percussion on the chest can help dislodge deep phlegm. If a patient cannot produce an acceptable sputum sample the first time, it is very unlikely that a repeat collection will yield a good specimen, and it is best to obtain an induced sputum. For noninvasive diagnosis of <emphasis>Legionella</emphasis> pneumonia, the use of urinary antigen tests is also recommended (<link linkend="ch0035s0035s0001li0015">15</link>).</para>
    </sect1>
    <sect1 id="ch0035s0006">
      <title>Stool</title>
      <anchor id="ch0035s0006a0001"/>
      <anchor id="ch0035s0006a0002"/>
      <para id="ch0035s0006p0001">Rectal swabs and stool specimens have comparable sensitivities for detection of enteric pathogens from bacterial culture and molecular tests (<link linkend="ch0035s0035s0001li0016">16</link>, <link linkend="ch0035s0035s0001li0017">17</link>). To collect a rectal swab, the swab should be inserted deep enough into the rectum to become visibly stained with stool. Many gastrointestinal stool pathogens are labile, so stool and rectal swabs should be submitted in transport media such as Cary-Blair or FecalSwab Cary-Blair (Copan, Murrieta, CA) to preserve viability of pathogens. Use of rectal swabs for molecular assays may require additional validation, as this is not an FDA-approved source.</para>
      <para id="ch0035s0006p0002">Testing more than one stool for bacterial pathogens is rarely indicated (<link linkend="ch0035s0035s0001li0004">4</link>). In adults, an enteric pathogen was detected in 87% of first stool samples, with a second sample increasing the positivity rate to 98% (<link linkend="ch0035s0035s0001li0018">18</link>). In pediatric patients, an enteric pathogen was detected in 98% of first stool specimens (<link linkend="ch0035s0035s0001li0019">19</link>). Diarrheal stool is loose and takes the shape of the container. Except for patients with documented ileus, formed stool should not be tested for <emphasis>C. difficile</emphasis>. In the general population, 4 to 15% of individuals are asymptomatic carriers of <emphasis>C. difficile</emphasis>, and testing carries the risk of an incorrect diagnosis and treatment (<link linkend="ch0035s0035s0001li0020">20</link>). Children younger than 2 years are also frequently colonized with toxigenic <emphasis>C. difficile</emphasis>, and testing is not recommended (<link linkend="ch0035s0035s0001li0004">4</link>) (see <ulink url="ch0073#ch0073s0001">chapter 56</ulink>, <emphasis>Clostridium</emphasis> and <emphasis>Clostridioides</emphasis>).</para>
    </sect1>
    <sect1 id="ch0035s0007">
      <title>Swabs</title>
      <anchor id="ch0035s0007a0001"/>
      <anchor id="ch0035s0007a0002"/>
      <anchor id="ch0035s0007a0003"/>
      <para id="ch0035s0007p0001">Although swabs are easy to collect, they should be avoided when tissue, aspirate, or biopsy material is available (<link linkend="ch0035s0035s0001li0004">4</link>). Swabs are prone to contamination by commensal microbiota and are particularly poor for recovery of mycobacteria and fungi. In particular, swabs from the surfaces of decubitus ulcers are not recommended for culture, as they are likely to yield colonizing bacteria that have superinfected the surface and the organisms recovered have poor correlation with those causing deep tissue or bone infection (<link linkend="ch0035s0035s0001li0021">21</link>).</para>
      <para id="ch0035s0007p0002">Swabs are generally preferred for collection of oropharyngeal samples, as it is technically easier to access the tonsils with a swab, and there are a limited number of media to inoculate. However, care should be taken to avoid touching noninvolved surfaces or mucosae, which harbor contaminating bacteria. Swabs are not recommended for diagnosis of sinusitis; aspirated material and tissue are preferred specimens. Endoscopically obtained swabs can recover bacterial pathogens but rarely detect fungi, which are common causes of chronic sinusitis (<link linkend="ch0035s0035s0001li0004">4</link>).</para>
      <para id="ch0035s0007p0003">However, new advances in swab technology have resulted in significant improvement on traditional swabs. Flocked swabs and E-swab transport systems (Copan, Murrieta, CA) have proven to be superior to wound swabs for the recovery of bacteria (<link linkend="ch0035s0035s0001li0022">22</link>). The fibers of flocked swabs have numerous microscopic folds that are perpendicular to the shaft, significantly increasing the surface area and improving the amount of specimen that is collected. The E-swab transport tube consists of 1 ml of liquid medium such as Amies or Stuart’s medium, and when the flocked swab is placed in the liquid transport medium and vortexed, specimen is released from the swab fibers. In addition to aerobic bacteria, anaerobic bacteria can survive at least 48 h at room temperature or refrigerated (<link linkend="ch0035s0035s0001li0023">23</link>). They also have the advantage of being compatible with automated front-end processing instruments (<link linkend="ch0035s0035s0001li0024">24</link>). Improved elution of specimen material from the swab and the use of a larger liquid sample volume likely contribute to the improved bacterial recovery (<link linkend="ch0035s0035s0001li0024">24</link>, <link linkend="ch0035s0035s0001li0025">25</link>).</para>
    </sect1>
    <sect1 id="ch0035s0008">
      <title>Tissues</title>
      <anchor id="ch0035s0008a0001"/>
      <anchor id="ch0035s0008a0002"/>
      <para id="ch0035s0008p0001">Tissue biopsy samples should be obtained by a surgeon using aseptic techniques. Surface skin should be disinfected with chlorhexidine-alcohol before the skin is cut. Once the first incision is made, which may inadvertently cut through a subsurface microcolony of commensal bacteria, the surgeon should switch to a fresh, sterile scalpel. Tissue should be placed into a sterile tube or cup with a tight lid. If anaerobes are considered likely, an anaerobic transport vial may be used to preserve anaerobe viability. Tissue from draining sinus lesions should be obtained by curetting deep within the interior of the tract after thorough surface skin disinfection. Swabs from the drainage are likely to harbor surface bacteria that may not be associated with the underlying infection and therefore should be avoided. Bone biopsy samples to diagnose osteomyelitis should be obtained directly from the bone itself after debridement of the overlying, usually superinfected tissue (<link linkend="ch0035s0035s0001li0026">26</link>). Infected bone is soft enough to easily be removed by curetting or sometimes by aspiration with a large-bore needle.</para>
    </sect1>
    <sect1 id="ch0035s0009">
      <title>Urine</title>
      <anchor id="ch0035s0009a0001"/>
      <anchor id="ch0035s0009a0002"/>
      <para id="ch0035s0009p0001">Urine can be collected by midstream collection, catheterization (straight in-and-out or indwelling), cystoscopic collection, or suprapubic aspiration. Boric acid preservative or prompt refrigeration of urine should be used to prevent overgrowth of bacteria that occurs at room temperature (<link linkend="ch0035s0035s0001li0027">27</link>). Foley catheter tips should not be submitted or accepted for culture, as they are always contaminated with members of the urethral microbiota and interpretation of results is not possible. Culture of pediatric bagged urine specimens, a plastic bag attached to the perineal region to collect urine from children too young to produce a midstream urine sample, should be discouraged for the same reason (<link linkend="ch0035s0035s0001li0028">28</link>).</para>
    </sect1>
    <sect1 id="ch0035s0010">
      <title>Volume and Size of Sample</title>
      <anchor id="ch0035s0010a0001"/>
      <anchor id="ch0035s0010a0002"/>
      <para id="ch0035s0010p0001">In general, the more material available for testing, the better. This is true especially when more than one type of culture is requested. However, receiving more than the necessary specimen volume or size to accommodate all requests can also be problematic. Health care providers should not send large bags of fluids, except in the case of peritoneal dialysate (from which the laboratory staff should remove 50 ml to concentrate by centrifugation), or very large pieces of tissue such as bone. Large specimens require more manipulation in the laboratory than necessary, which can introduce contaminants or result in a less productive part of the sample being selected for testing. When possible, at least 1 ml of fluid and 1 g or 1 cm<superscript>3</superscript> of tissue should be submitted for Gram staining and routine bacterial culture; more may be necessary for additional studies (<link linkend="ch0035s0035s0001li0029">29</link>). If the volume received is not sufficient to perform all requests or to inoculate all the usual media, the physician should be contacted to prioritize the requests. This not only helps the microbiologist to perform the appropriate test but also alerts the physician that the sample was problematic and could serve to motivate collection of adequate specimens in the future. Suggested blood volumes are described in the section on blood cultures (also see <link linkend="ch0035s0020a0003">Table 6</link>).</para>
    </sect1>
    <sect1 id="ch0035s0011">
      <title>Specimen Transport</title>
      <anchor id="ch0035s0011a0001"/>
      <anchor id="ch0035s0011a0002"/>
      <para id="ch0035s0011p0001">The type of test to be performed determines the nature of the transport system. The performance of various swab types and transport media should be verified prior to implementation. Manufacturers are required to do this, and laboratories also perform verifications of transport devices. For example, some nonviable bacteria in transport media (allowed per U.S. Food and Drug Administration [FDA] specifications) may be seen in initial Gram stains of specimens received in anaerobic transport media, so microbiologists may wish to sample several lots of the product to ascertain a low burden of dead but stainable organisms. The Clinical and Laboratory Standards Institute has developed standards for evaluating transport devices (<link linkend="ch0035s0035s0001li0030">30</link>). <link linkend="ch0035s0003a0011">Table 1</link> summarizes transport recommendations for routine bacteriology.</para>
      <orderedlist>
        <listitem id="ch0035s0011li0001">
          <para>Transport specimens to the laboratory as soon as possible after collection. For most specimens, if transport will require more than 2 h, either a specific transport medium or refrigeration is required (<link linkend="ch0035s0003a0011">Table 1</link>). For samples to be tested by molecular methods only, refrigeration or even freezing (−80°C is best) is acceptable. The manufacturer’s recommended or companion transport materials must be used for commercial molecular assays. Any deviation from the product insert in sample collection and handling for any <emphasis>in vitro</emphasis> diagnostic test requires the laboratory to perform a verification of the performance of the assay.</para>
        </listitem>
        <listitem id="ch0035s0011li0002">
          <para>Inoculate bacterial culture media within 24 h even if appropriate transport medium or refrigeration is maintained.</para>
        </listitem>
        <listitem id="ch0035s0011li0003">
          <anchor id="ch0035s0011a0003"/>
          <para>Small volumes of fluid (≤1 ml) or tissue (≤1 cm<superscript>3</superscript>) should be submitted within 15 to 30 min to avoid evaporation, drying, and exposure to ambient conditions. A few drops of nonbacteriostatic saline may be added for hydration. Larger volumes and specimens in appropriate transport medium may be stored for as long as 24 h.</para>
        </listitem>
        <listitem id="ch0035s0011li0004">
          <para>Bacteria that are especially sensitive to ambient conditions include<emphasis>Shigella</emphasis> spp., <emphasis>Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae, Bordetella pertussis</emphasis>, and anaerobes. Reliable detection of these species requires rapid processing. Delays of up to 6 h result in some loss of CFU even when transport media are used (<link linkend="ch0035s0035s0001li0030">30</link>–<link linkend="ch0035s0035s0001li0032">32</link>). Longer delays result in significant loss of organisms. For delays beyond 6 h, refrigeration improves recovery (<link linkend="ch0035s0035s0001li0030">30</link>).</para>
        </listitem>
        <listitem id="ch0035s0011li0005">
          <para>Moving clinical specimens from one laboratory to another, regardless of the distance and vehicle used, requires adherence to specimen packaging and labeling instructions mandated by the federal government. Materials for transport must be labeled properly, packaged to enable absorption and containment of any liquid released during a break or spill, and protected during transport. See the Centers for Disease Control and Prevention (CDC) website (<ulink url="http://www.cdc.gov/od/eaipp/shipping/">http://www.cdc.gov/od/eaipp/shipping/</ulink>) and the International Air Transport Association (<ulink url="http://www.iata.org/publications/dgr/pages/index.aspx">http://www.iata.org/publications/dgr/pages/index.aspx</ulink>) for more information.</para>
        </listitem>
        <listitem id="ch0035s0011li0006">
          <para>For detection of selected fastidious organisms, the laboratory should provide clear instructions for transport methods (<link linkend="ch0035s0035s0001li0033">33</link>). If specimens are to be shipped to a distant reference laboratory, the reference laboratory’s conditions and requests must be met, and in many instances, the laboratory provides transport devices to users. Continuous dialogue with health care providers ensures that the appropriate information on collection and transport is accessed before specimen collection begins.</para>
        </listitem>
      </orderedlist>
      <sect2 id="ch0035s0011s0001">
        <title>HANDLING OF SPECIMENS IN THE LABORATORY</title>
        <anchor id="ch0035s0011s0001a0001"/>
        <anchor id="ch0035s0011s0001a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0035s0012">
      <title>Documentation of Arrival, Condition, and Appropriate Sample for Test Ordered</title>
      <anchor id="ch0035s0012a0001"/>
      <anchor id="ch0035s0012a0002"/>
      <para id="ch0035s0012p0001">Upon arrival of specimens in the laboratory, the time and date of receipt should be recorded. All specimens and requisitions should be carefully inspected. Specimens must be correctly labeled and, if accompanied by a requisition form, contain at least two patient identifiers. The requisition form must include the patient’s name, age, sex, identifying number (such as medical record number or unique registration/billing number), ordering location (hospital location, physician’s office address, etc.), the ordering physician’s name; the specimen source (detailed), the date and time of collection, and the test ordered. If an electronic laboratory system is used, all of the relevant information mentioned in this section is usually captured. If a specimen is mislabeled or no patient name is provided, the specimen should be rejected and another specimen should be collected. If another specimen cannot be collected (for example, tissue collected during a surgical procedure), the physician or nurse should be contacted and personally identify the specimen. When relabeling has occurred, the course of events must be outlined in the laboratory report so that the physician interpreting the results is aware of potential errors. Each specimen processed in the laboratory should receive a unique laboratory accession number. Subsequently, the time of plating, which may differ substantially from the time of receipt, should be recorded.</para>
    </sect1>
    <sect1 id="ch0035s0013">
      <title>Specimen Rejection</title>
      <anchor id="ch0035s0013a0001"/>
      <anchor id="ch0035s0013a0002"/>
      <para id="ch0035s0013p0001">Some specimen collection sites, transport containers, or transport conditions render the specimen unacceptable for processing (<link linkend="ch0035s0035s0001li0034">34</link>). <link linkend="ch0035s0003a0011">Table 1</link> lists acceptable criteria for specimen management based on collection or transport conditions and times. When specimens fall outside these limits (too long in transit, incorrect temperature, not in proper transport medium, wrong site for requested test, etc.), new specimens should be collected whenever possible. <anchor id="ch0035s0013a0003"/><link linkend="ch0035s0014a0004">Table 3</link> lists unacceptable specimen types for anaerobic culture requests that should be rejected. Major reasons for rejection include inappropriate transport conditions, poor quality of specimen material collected, and inappropriate specimen type for the test requested (<link linkend="ch0035s0014a0004">Tables 3</link> and <anchor id="ch0035s0013a0004"/><link linkend="ch0035s0014a0005">4</link>).</para>
      <para id="ch0035s0013p0002">Specimens are rejected by contacting the patient’s health care provider, explaining the reason for rejection, and requesting a replacement specimen of acceptable quality. Timely notification and collection of replacement specimens are necessary, especially in instances where antimicrobial therapy has been initiated. Specimen rejection criteria should be reviewed by appropriate laboratory and medical staff representatives before becoming policy. Specimens determined to have gross bacterial contamination by members of the microbiota, such as sputum specimens with an abundance of SECs seen on initial Gram stain, should be rejected.</para>
    </sect1>
    <sect1 id="ch0035s0014">
      <title>Handling Samples That Are To Be Processed at a Remote Site</title>
      <anchor id="ch0035s0014a0001"/>
      <anchor id="ch0035s0014a0002"/>
      <para id="ch0035s0014p0001">Transport and processing time limits suitable for laboratories near the specimen collection site are not appropriate for remote laboratories. Specimens must be handled in the same manner regardless of whether they are to be transported via public or private mail service. See the CDC Office of Health and Safety site and the Pipeline and Hazardous Materials Safety Administration site (<ulink url="https://www.phmsa.dot.gov/training/hazmat/transporting-infectious-substances-safely">https://www.phmsa.dot.gov/training/hazmat/transporting-infectious-substances-safely</ulink>) for the latest guidelines. Managing movement of specimens using temperature-controlled boxes, reliable courier service, and good tracking systems remains a challenge for many providers.</para>
      <anchor id="ch0035s0014a0003"/>
      <beginpage pagenum="370"/>
      <table id="ch0035s0014t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0014a0004"/><link linkend="ch0035s0013a0003">TABLE 3</link></phrase></emphasis> Suitability of various specimens for anaerobic culture
</title>
        
        <tgroup cols="2">
          <tbody>
            <row>
              <entry>Acceptable material</entry>
              <entry>Unacceptable material</entry>
            </row>
            <row>
              <entry>Aspirate</entry>
              <entry>Bronchoalveolar lavage washing</entry>
            </row>
            <row>
              <entry>Blood</entry>
              <entry>Cervical or vaginal secretions</entry>
            </row>
            <row>
              <entry>Bone marrow aspirate</entry>
              <entry>Endotracheal secretions</entry>
            </row>
            <row>
              <entry>Bronchoscopic lavage (protected specimen brush)</entry>
              <entry>Nasopharyngeal swab</entry>
            </row>
            <row>
              <entry>IUD for<emphasis>Actinomyces</emphasis> spp.</entry>
              <entry>Prostatic or seminal fluid</entry>
            </row>
            <row>
              <entry>Nasal sinus aspirate</entry>
              <entry>Sputum</entry>
            </row>
            <row>
              <entry>Placenta tissue</entry>
              <entry>Tracheostomy secretions</entry>
            </row>
            <row>
              <entry>Surgical aspirate or tissue</entry>
              <entry>Urethral secretions</entry>
            </row>
            <row>
              <entry>Cystoscopic urine</entry>
              <entry>Urine (nonsurgically collected)</entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <table id="ch0035s0014t0002"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0014a0005"/><link linkend="ch0035s0013a0004">TABLE 4</link></phrase></emphasis> Suggested rejection criteria for specimens submitted for culture<superscript><link linkend="ch0035s0014a0007"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0014a0006"/>
</title>
        
        <tgroup cols="2">
          <tbody>
            <row>
              <entry>Specimen</entry>
              <entry>Comment</entry>
            </row>
            <row>
              <entry>Sputum specimen with ≥25 SECs per LPF (10×)</entry>
              <entry>Most likely represents saliva. Request new specimen.</entry>
            </row>
            <row>
              <entry>Dry swab (not in transport container)</entry>
              <entry/>
            </row>
            <row>
              <entry>Single swab or small fluid volume (≤1 ml) or tissue (≤1 cm<superscript>3</superscript>) for multiple tests: Gram stain, aerobic, anaerobic bacteria culture, AFB smear and culture, viral tests, etc.</entry>
              <entry>Ask physician to prioritize tests</entry>
            </row>
            <row>
              <entry>Swab for AFB or fungal smear and culture</entry>
              <entry>Request tissue or aspirate</entry>
            </row>
            <row>
              <entry>Unpreserved urine ≥24 h</entry>
              <entry/>
            </row>
            <row>
              <entry>Foley catheter tip</entry>
              <entry/>
            </row>
            <row>
              <entry>Duplicate (≥1 specimen) on same day: urine, stool, sputum, wound, and throat</entry>
              <entry/>
            </row>
            <row>
              <entry>Specimen container not labeled or different labels than requisition form</entry>
              <entry>Request new specimen or ask physician/nurse to identify and correct specimen labeling in person for irreplaceable specimens</entry>
            </row>
            <row>
              <entry>Improper, nonsterile container or container in which part of specimen has leaked</entry>
              <entry>Request new specimen. If additional material cannot be collected, alert physician/nurse that specimen may have been contaminated and document in records.</entry>
            </row>
            <row>
              <entry>Specimen received in formalin</entry>
              <entry/>
            </row>
            <row>
              <entry>Specimen for anaerobic culture not received in anaerobic transport system</entry>
              <entry>Unless tissue from surgical room transported immediately to the laboratory in sterile container or fluid in capped syringe without needle</entry>
            </row>
            <row>
              <entry>Central venous catheter tip without concomitant blood cultures</entry>
              <entry>Request blood cultures be drawn to aid in interpretation</entry>
            </row>
            <row>
              <entry>Nasopharyngeal swabs for bacterial culture</entry>
              <entry>Not predictive of sinus, middle ear, or lower respiratory tract infection</entry>
            </row>
            <row>
              <entry>Culture of lochia, cervix, urethra, samples for other than<emphasis>N. gonorrhoeae</emphasis> or group B <emphasis>Streptococcus</emphasis></entry>
              <entry/>
            </row>
            <row>
              <entry>Culture of gastric aspirates or bowel contents, e.g., colon, ileostomy, or colostomy</entry>
              <entry/>
            </row>
            <row>
              <entry>Formed stool for<emphasis>C. difficile</emphasis> toxin testing</entry>
              <entry>Use objective criteria such as Bristol stool score or “stick test” (<link linkend="ch0035s0035s0001li0140">140</link>). Rectal swab is acceptable for patients with ileus.</entry>
            </row>
            <row>
              <entry>Stool culture for enteric pathogens for inpatients ≥3 days</entry>
              <entry>Low yield in patients hospitalized ≥3 days.</entry>
            </row>
            <row>
              <entry>Culture of implantable devices, e.g., pacemakers, leads, screws, plates, penile implants, etc.</entry>
              <entry>Request tissue or fluid. Reasonable alternatives include sonication of device (but requires specialized equipment), or add sterile saline, vortex, and aliquot samples to culture plates.</entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><link linkend="ch0035s0014a0006"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0014a0007"/>Abbreviations: LPF, low-power field; AFB, acid-fast bacilli.</para>
    </sect1>
    <sect1 id="ch0035s0015">
      <title>Prioritization</title>
      <anchor id="ch0035s0015a0001"/>
      <anchor id="ch0035s0015a0002"/>
      <para id="ch0035s0015p0001">For busy laboratories that receive many samples over a short period, it is helpful to develop a priority list to assist accessioning staff in determining the order in which samples should be processed (<link linkend="ch0035s0035s0001li0003">3</link>, <link linkend="ch0035s0035s0001li0034">34</link>). Gram staining of cerebrospinal fluid (CSF), positive blood culture broth, surgical specimens, and sterile body fluid specimens should receive the highest priority.</para>
    </sect1>
    <sect1 id="ch0035s0016">
      <title>Initial Sample Handling</title>
      <anchor id="ch0035s0016a0001"/>
      <anchor id="ch0035s0016a0002"/>
      <orderedlist>
        <listitem id="ch0035s0016li0001">
          <para>Swabs should be inoculated onto medium plates, with the least inhibitory medium being inoculated first. For flocked swabs in liquid media, the specimen should be mixed by vortexing; either application of specimen using the swab or drops of the suspension can be used to prepare the slide and inoculate media.</para>
        </listitem>
        <listitem id="ch0035s0016li0002">
          <para>Sputum is best sampled from the container with wooden sticks, which do not absorb the fluid sections but stick to the more purulent portions, where the pathogens are likely to be.</para>
        </listitem>
        <listitem id="ch0035s0016li0003">
          <para>Clear fluids other than urine should be concentrated on a slide using a cytocentrifuge. If a cytocentrifuge is not available, samples of ≥1 ml should be centrifuged (1,500 ×<emphasis>g</emphasis> for 15 min) and the supernatant removed with a pipette down to 1.0 ml (<link linkend="ch0035s0035s0001li0035">35</link>). This sediment is mixed thoroughly (vortex or pipette) and used for testing. If the material is thick, bloody, or frank pus, it should be applied to the slide without concentration and smeared thinly, similar to making a thin blood film.</para>
        </listitem>
        <listitem id="ch0035s0016li0004">
          <para>Tissue and bone for bacteriology cultures should be ground in a mortar and pestle, or tissue may be dispersed in an automated stomacher (Seward Limited, Worthing, West Sussex, United Kingdom). A drop of this suspension should be struck to obtain isolated colonies. If fungal cultures are requested, tissue and bone should be minced (not ground) using a sterile scalpel and a small piece of intact tissue inoculated into the surface of each agar medium to preserve the viability of members of the<emphasis>Mucorales</emphasis>.</para>
        </listitem>
        <listitem id="ch0035s0016li0005">
          <anchor id="ch0035s0016a0003"/>
          <para>A Gram stain should be examined for all fluids and tissues and some swabs, such as those received for diagnosis of bacterial vaginosis (BV) (<anchor id="ch0035s0016a0004"/><link linkend="ch0035s0016a0008">Table 5</link>). Gram stains can deliver rapid, actionable results to clinicians, can determine if a specimen is acceptable for culture based on cellularity, and should be used to aid the microbiologist in interpretation of the culture (<link linkend="ch0035s0035s0001li0034">34</link>). Infection gives rise to purulence (abundant polymorphonuclear cells), blood, necrosis, and mucus (mucous membrane specimens). In general, gross examination of the specimen should identify yellow to tan purulence, red to rust-colored blood, clear and tenacious mucus, and brown to black discoloration of necrotic tissue. Portions for smear and culture should be taken from these areas. Ideally, microscopic examination of smears, using a 10× microscope objective, should demonstrate many polymorphonuclear cells (PMNs) and few or no SECs, which would suggest cutaneous or mucocutaneous contamination with members of the normal bacterial microbiota (<anchor id="ch0035s0016a0005"/><link linkend="ch0035s0016a0010">Fig. 1</link> and <anchor id="ch0035s0016a0006"/><link linkend="ch0035s0016a0012">2</link>).</para>
        </listitem>
        <listitem id="ch0035s0016li0006">
          <anchor id="ch0035s0016a0007"/>
          <para>Based on the site of the sample and physicians’ requests, each specimen should be inoculated to an appropriate medium chosen to recover suspected pathogens (<link linkend="ch0035s0016a0008">Table 5</link>). In this era of diminishing resources, two relatively recent innovations improve this process: chromogenic agars and automated plate inoculators. Chromogenic agars produce colonies that can be identified to genus or species level directly from the appearance of the colonies without any further testing. Not only are they available for urinary tract pathogens (<link linkend="ch0035s0035s0001li0036">36</link>) and some stool pathogens (<link linkend="ch0035s0035s0001li0037">37</link>), but they are also widely used for screening samples for resistant bacteria, such as methicillin-resistant <emphasis>Staphylococcus aureus</emphasis> (MRSA), vancomycin-resistant enterococci (VRE), and multidrug-resistant Gram-negative rods (<link linkend="ch0035s0035s0001li0038">38</link>, <link linkend="ch0035s0035s0001li0039">39</link>). In some cases, they may be cost-effective by virtue of reducing both time and reagents used to identify the organisms compared to the conventional manner.</para>
        </listitem>
      </orderedlist>
      <table id="ch0035s0016t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0016a0008"/><link linkend="ch0035s0016a0004">TABLE 5</link></phrase></emphasis> Recommendations for Gram stain and plating media for bacteriology specimens or organisms<superscript><emphasis>a</emphasis></superscript>
</title>
        
        <tgroup cols="5">
          <tbody>
            <row>
              <entry>Specimen or organism</entry>
              <entry><phrase role="center">Gram stain</phrase>
              </entry>
              <entry><phrase role="center">Aerobic medium</phrase>
              </entry>
              <entry><phrase role="center">Anaerobic medium<superscript><emphasis>b</emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">Comments</phrase>
              </entry>
            </row>
            <row>
              <entry>Body cavity fluids</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry>If sufficient volume exists, residual sterile body fluids should be inoculated into blood culture bottles for increased sensitivity of detection.</entry>
            </row>
            <row>
              <entry>CSF (lumbar puncture)</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>CSF (shunt)</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac, Th</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Pericardial</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C</entry>
              <entry><phrase role="center">BBA</phrase>
              </entry>
              <entry/>
            </row>
            <row>
              <entry>Pleural</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C</entry>
              <entry><phrase role="center">BBA</phrase>
              </entry>
              <entry/>
            </row>
            <row>
              <entry>Peritoneal</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac, CNA</entry>
              <entry><phrase role="center">BBA, LKV, BBE</phrase>
              </entry>
              <entry/>
            </row>
            <row>
              <entry>CAPD</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Th</entry>
              <entry><phrase role="center">BBA</phrase>
              </entry>
              <entry>Inoculate fluid into blood culture bottle at bedside</entry>
            </row>
            <row>
              <entry>Synovial</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C</entry>
              <entry/>
              <entry>Inoculate fluid into blood culture bottle if sufficient volume</entry>
            </row>
            <row>
              <entry>Bone marrow</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C</entry>
              <entry><phrase role="center">BBA</phrase>
              </entry>
              <entry>Inoculate fluid into blood culture bottle if sufficient volume</entry>
            </row>
            <row>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry>Isolator system for detection of<emphasis>Brucella</emphasis> and intracellular bacteria</entry>
            </row>
            <row>
              <entry>Catheter tip</entry>
              <entry/>
              <entry>B</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Ear external fluid/swab</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Ear internal fluid</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C</entry>
              <entry><phrase role="center">BBA</phrase>
              </entry>
              <entry/>
            </row>
            <row>
              <entry>Eye</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Genitourinary tract</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Vagina/cervix</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, TM</entry>
              <entry/>
              <entry>Gram stain is method of choice for diagnosis of BV.</entry>
            </row>
            <row>
              <entry>Urethra/penis</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>TM</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Other</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac, TM, CNA</entry>
              <entry><phrase role="center">BBA, LKV, BBE</phrase>
              </entry>
              <entry/>
            </row>
            <row>
              <entry>Group B streptococcal screen (vaginal/rectal screen)</entry>
              <entry/>
              <entry>Selective broth, subculture to B, chromogenic screening agars</entry>
              <entry/>
              <entry>PCR can be performed from enrichment broth.</entry>
            </row>
            <row>
              <entry>Lower respiratory tract</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Sputum</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac (BCSA/OFBPL, mannitol salt, and IMA for cystic fibrosis)</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Tracheal aspirate</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Bronchoalveolar lavage fluid</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac, CNA</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Bronchoalveolar brushing, washing</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac, CNA</entry>
              <entry><phrase role="center">BBA, LKV</phrase>
              </entry>
              <entry>Only protected bronchoscopic brushing (in anaerobic transport) acceptable for anaerobic culture</entry>
            </row>
            <row>
              <entry>Tissue</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac, CNA, Th</entry>
              <entry><phrase role="center">BBA, LKV, BBE</phrase>
              </entry>
              <entry/>
            </row>
            <row>
              <entry>Upper respiratory tract</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Nasopharynx</entry>
              <entry/>
              <entry>B, C</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Nose</entry>
              <entry/>
              <entry>B, chromogenic agar (MRSA screening)</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Throat</entry>
              <entry/>
              <entry>B or SSA</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Stool</entry>
              <entry/>
              <entry>B, Mac, HE, CAMPY, EB (optional); sorbitol-Mac/chromogenic agar/Shiga toxin testing</entry>
              <entry/>
              <entry>Incubate CA<emphasis>MPY</emphasis> media for <emphasis>C. jejuni</emphasis>/<emphasis>C. coli</emphasis> in 5% O<subscript>2</subscript>–10% CO<subscript>2</subscript>–85% N<subscript>2</subscript> at 42°C</entry>
            </row>
            <row>
              <entry>Urine</entry>
              <entry/>
              <entry>B, Mac, or chromogenic agar</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Wound or abscess</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Swab</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac, CNA</entry>
              <entry><phrase role="center">BBA, LKV, BBE</phrase>
              </entry>
              <entry>Aspirate or tissue is preferred; anaerobic culture should not be performed on noninvasive swabs.</entry>
            </row>
            <row>
              <entry>Aspirate</entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>B, C, Mac, CNA</entry>
              <entry><phrase role="center">BBA, LKV, BBE</phrase>
              </entry>
              <entry/>
            </row>
            <row>
              <entry><emphasis>B. pertussis</emphasis> and <emphasis>B. parapertussis</emphasis></entry>
              <entry/>
              <entry>Regan-Lowe</entry>
              <entry/>
              <entry>NAAT is more sensitive than culture</entry>
            </row>
            <row>
              <entry><emphasis>Brucella</emphasis> spp.</entry>
              <entry/>
              <entry>B, C</entry>
              <entry/>
              <entry>Consider including Isolator tube</entry>
            </row>
            <row>
              <entry><emphasis>C. diphtheriae</emphasis>
              </entry>
              <entry/>
              <entry>Cystine-tellurite or Loeffler’s serum</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><emphasis>C. difficile</emphasis>
              </entry>
              <entry/>
              <entry>CCFA</entry>
              <entry/>
              <entry>NAAT is more sensitive than culture</entry>
            </row>
            <row>
              <entry><emphasis>E. coli</emphasis> O157:H7 (EHEC, STEC)</entry>
              <entry/>
              <entry>Sorbitol-Mac/chromogenic agar</entry>
              <entry/>
              <entry>Shiga toxin EIA and NAAT more sensitive than culture</entry>
            </row>
            <row>
              <entry><emphasis>F. tularensis</emphasis>
              </entry>
              <entry/>
              <entry>C or BCYE</entry>
              <entry/>
              <entry>Consider including Isolator tube</entry>
            </row>
            <row>
              <entry><emphasis>H. pylori</emphasis>
              </entry>
              <entry/>
              <entry>BHI, CNA, and others (see<ulink url="ch0077#ch0077s0001">chapter 60</ulink>)</entry>
              <entry/>
              <entry>Requires incubation in Campylobacter gaseous atmosphere at 35–37°C</entry>
            </row>
            <row>
              <entry><emphasis>Legionella</emphasis> spp.</entry>
              <entry/>
              <entry>BCYE</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><emphasis>Leptospira</emphasis>
              </entry>
              <entry/>
              <entry>Fletcher’s medium or EMJH</entry>
              <entry/>
              <entry>30°C for up to 13 wk</entry>
            </row>
            <row>
              <entry><emphasis>N. gonorrhoeae</emphasis>
              </entry>
              <entry><phrase role="center">x</phrase>
              </entry>
              <entry>TM</entry>
              <entry/>
              <entry><para>NAAT is more sensitive than culture</para>
                <para id="ch0035s0016p0001">Gram stain may be performed on adult male urethral specimens</para>
              </entry>
            </row>
            <row>
              <entry><emphasis>Vibrio</emphasis> spp.</entry>
              <entry/>
              <entry>TCBS</entry>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><emphasis>Y. enterocolitica</emphasis>
              </entry>
              <entry/>
              <entry>CIN or MAC</entry>
              <entry/>
              <entry>Incubate at 30°C</entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <figure id="ch0035s0016f0001"><title><anchor id="ch0035s0016a0009"/><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0016a0010"/><link linkend="ch0035s0016a0005">FIGURE 1</link></phrase></emphasis> Gram stain (original magnification, ×100) of an unacceptable sputum specimen (grossly contaminated with members of the oropharyngeal microbiota) showing &gt;10 SECs per low-power field.
</title>
        
        <mediaobject>
          <imageobject>
            <imagedata fileref="Ch0035f03.jpg" width="100%" scalefit="1"/>
          </imageobject>
        </mediaobject>
      </figure>
      <para id="ch0035s0016p0002">Several automated medium inoculators are commercially available that, in general, perform at least as well as manual plating and reduce workload for short-staffed laboratories (<link linkend="ch0035s0035s0001li0040">40</link>). Some require that the sample be inoculated onto the plate, while others handle the container containing any liquid specimen, including E-swabs (<link linkend="ch0035s0035s0001li0041">41</link>). These instruments are being adopted with increasing frequency as laboratory staffing becomes leaner.</para>
      <para id="ch0035s0016p0003">Enrichment broth should be used only when appropriate (<link linkend="ch0035s0016a0008">Table 5</link>). For samples such as superficial swabs, broth cultures are more likely to yield contaminating members of the skin microbiota than pathogens (<link linkend="ch0035s0035s0001li0042">42</link>). When fastidious species or organisms may be present in small numbers, such as with cardiac valves, the use of enrichment broths may be warranted. When simultaneously inoculated plates yield growth, it is rarely useful or efficient to continue to work with the broth. When initial plates do not show growth in the face of a sample with PMNs or other suggestions of an infectious process, subculture of the enrichment broth may be informative. Growth of skin organisms such as coagulase-negative <emphasis>Staphylococcus, Propionibacterium</emphasis>, and <emphasis>Cutibacterium</emphasis> species must be evaluated in concert with clinical criteria to avoid overinterpretation (<link linkend="ch0035s0035s0001li0043">43</link>).</para>
      <figure id="ch0035s0016f0002"><title><anchor id="ch0035s0016a0011"/><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0016a0012"/><link linkend="ch0035s0016a0006">FIGURE 2</link></phrase></emphasis> Gram stain (original magnification, ×100) of an acceptable sputum specimen showing &lt;10 SECs per low-power field.
</title>
        
        <mediaobject>
          <imageobject>
            <imagedata fileref="Ch0035f02.jpg" width="100%" scalefit="1"/>
          </imageobject>
        </mediaobject>
      </figure>
      <para id="ch0035s0016p0004">Once inoculated to the appropriate media based on the laboratory’s protocols (<link linkend="ch0035s0016a0008">Table 5</link>), plates and broths are incubated in the appropriate atmosphere before they are examined for growth. Chocolate plates are always incubated in 5% CO<subscript>2</subscript>, blood may be incubated in either air or CO<subscript>2</subscript> (depending on the requirements of the organisms to be recovered), and selective agar plates are best incubated in air. Special incubation atmospheres, such as microaerophilic conditions, are mentioned in the chapters covering the species that require them. Unless otherwise noted, ideal temperatures for bacterial growth are 35 to 37°C.</para>
      <anchor id="ch0035s0016a0013"/>
      <beginpage pagenum="373"/>
      <para id="ch0035s0016p0005">Specimens for anaerobic culture should be processed as soon as possible after arrival in the laboratory. Usual media can include an anaerobic blood agar plate (CDC blood agar or brucella blood agar), a medium that inhibits Gram-positive and facultative Gram-negative bacilli (such as KV [kanamycin-vancomycin] blood agar), a differential or selective medium (such as bacteroides bile esculin), a Gram-positive selective medium (colistin-nalidixic acid blood agar or phenylethyl alcohol blood agar), and an enrichment broth (such as chopped meat carbohydrate or thioglycolate) (<link linkend="ch0035s0016a0008">Table 5</link>). Media should be incubated in an anaerobic environment immediately after inoculation (see <ulink url="ch0070#ch0070s0001s0001">chapter 53</ulink>, Approach to Identification of Anaerobic Bacteria).</para>
      <orderedlist>
        <listitem id="ch0035s0016li0007">
          <para>For many reasons, it is best to retain specimens, including empty containers if the entire specimen was used. Sometimes additional tests are requested after other results, such as histopathology, become available. Sometimes there is an error during laboratory processing and the original aliquot must be resampled. Other reasons include the need to check the label on the specimen, to prepare a second smear if there is a question on interpretation of the first one, or to examine the gross appearance of the sample. If possible, specimens should be stored in a refrigerator or ultracold freezer for a minimum of 5 days.</para>
        </listitem>
      </orderedlist>
    </sect1>
    <sect1 id="ch0035s0017">
      <title>Specimen Transport for Molecular Detection of Bacteria</title>
      <anchor id="ch0035s0017a0001"/>
      <anchor id="ch0035s0017a0002"/>
      <para id="ch0035s0017p0001">Recommended procedures and transport systems for molecular detection of bacteria vary depending on the test system employed. Fresh stool or stool collected in Cary-Blair transport medium is suitable for testing using multiplex gastrointestinal panels and molecular assays for<emphasis>C. difficile</emphasis>. Tissue is sometimes submitted for detection of bacterial pathogens using molecular amplification or DNA sequencing and should be collected aseptically in a sterile container. For commercial or specialized molecular tests, the transport system should be specific for the type of test. Recent IDSA/ASM guidelines address these issues (<link linkend="ch0035s0035s0001li0004">4</link>). Special swabs with proprietary transport medium or first-void urine specimens (≤30 ml) are often required for molecular detection of <emphasis>N. gonorrhoeae</emphasis> and <emphasis>Chlamydia trachomatis</emphasis>.</para>
      <sect2 id="ch0035s0017s0001">
        <title>LABORATORY SAFETY ISSUES REGARDING BACTERIAL PATHOGENS</title>
        <anchor id="ch0035s0017s0001a0001"/>
        <anchor id="ch0035s0017s0001a0002"/>
        <para id="ch0035s0017s0001p0001">Laboratory personnel should always maintain a level of suspicion that any specimen could harbor a highly infectious agent. Physicians should be educated to alert the laboratory when they suspect the possibility of any pathogen associated with laboratory-acquired infections, including<emphasis>Coccidioides immitis-Coccidioides posadasii, Brucella</emphasis>, and <emphasis>Francisella tularensis</emphasis> (<link linkend="ch0035s0035s0001li0044">44</link>). Laboratorians should obtain recommended vaccines, including those against <emphasis>N. meningitidis</emphasis> and other pathogens if the laboratory is expected to encounter them. All specimen processing should be performed in a biosafety level 2 (BSL-2) cabinet to prevent contamination of specimens, and staff should wear personal protective equipment, including a splash-proof gown and gloves, to minimize accidental exposures. Any laboratorians who process specimens that could generate aerosols or who might have to enter an environment where aerosols are possible must be fit tested for an N95 mask or similar protective face shield respirator. These masks should be worn in any situation where aerosols are possible. The Occupational Safety and Health Administration mandates the Respiratory Protection Standard specifically for potential tuberculosis or severe acute respiratory syndrome coronavirus exposures, but other regulatory agencies and most employers have extended these rules to other respiratory hazards (<ulink url="https://www.osha.gov/SLTC/respiratoryprotection/standards.html">https://www.osha.gov/SLTC/respiratoryprotection/standards.html</ulink>). The CDC’s most recent biosafety manual, found at <ulink url="http://www.cdc.gov/biosafety/publications/bmbl5/bmbl.pdf">http://www.cdc.gov/biosafety/publications/bmbl5/bmbl.pdf</ulink>, has guidelines for research and clinical laboratories. A CDC-produced article in <emphasis>Morbidity and Mortality Weekly Report</emphasis> provides additional information about safety in clinical laboratories (<ulink url="http://www.cdc.gov/mmwr/preview/mmwrhtml/su6101a1.htm">http://www.cdc.gov/mmwr/preview/mmwrhtml/su6101a1.htm</ulink>). <ulink url="ch0029#ch0029s0001">Chapter 14</ulink> (Prevention of Laboratory-Acquired Infections) contains a more in-depth discussion of biosafety in the laboratory.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0035s0018">
      <title>Engineering Controls</title>
      <anchor id="ch0035s0018a0001"/>
      <anchor id="ch0035s0018a0002"/>
      <para id="ch0035s0018p0001">Laboratory environments should be designed to protect workers from biohazards inherent in the nature of the work. Ready access to properly maintained and certified BSL-2 laminar-flow biological cabinets and good training in the proper use of such equipment are important (see<ulink url="ch0029#ch0029s0001">chapter 14</ulink>, Prevention of Laboratory-Acquired Infections). When BSL-2 cabinets are not available, all manipulations that may result in aerosol formation and those involving samples containing blood or body fluids (such as procedures involving blood culture bottles) should be performed behind a Plexiglas or other clear shield. Specimen containers should be carried within the laboratory in trays with solid sides and bottoms to prevent spillage if dropped accidentally. Plates that are suspected to harbor growth of any dangerous pathogen should be taped on both sides to allow circulation of atmosphere but not allow accidental opening. All laboratory workers should know what to do in the event of a spill or accidental release in the laboratory, and drills should be conducted periodically to reinforce proper responses.</para>
      <sect2 id="ch0035s0018s0001">
        <title>SPECIFIC SPECIMEN COLLECTION AND PROCESSING RECOMMENDATIONS (ALSO SEE TABLE 7)</title>
        <anchor id="ch0035s0018s0001a0001"/>
        <anchor id="ch0035s0018s0001a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0035s0019">
      <title>Autopsy Samples</title>
      <anchor id="ch0035s0019a0001"/>
      <anchor id="ch0035s0019a0002"/>
      <para id="ch0035s0019p0001">Microbiology testing as a component of the autopsy examination has been controversial (<link linkend="ch0035s0035s0001li0045">45</link>). Postmortem and agonal invasion of sterile tissues confuses the significance of positive culture results, prompting some to argue against microbiology testing. Others found that postmortem examination continues to uncover a significant number of diagnoses of infectious diseases (<link linkend="ch0035s0035s0001li0045">45</link>). To minimize contamination of postmortem specimens, the body should be moved to a refrigerated locker (4 to 6°C) as soon as possible after death, and specimens should be collected from refrigerated bodies within 15 h of death. This serves to diminish the likelihood of postmortem overgrowth of contaminants and improve detection of true pathogens.</para>
      <anchor id="ch0035s0019a0003"/>
      <beginpage pagenum="374"/>
      <para id="ch0035s0019p0002">Specimens should be obtained by sterilizing the surface of the organ with a hot spatula or iron surface until the surface is thoroughly dry. Body fluids, including blood, should be collected first. For blood collection, the wall of the heart and large vessel should be seared and a sterile needle (18 to 20 gauge) inserted. A 20-ml volume should be collected and injected directly into aerobic and anaerobic blood culture bottles. Solid viscera should be sampled by immediately cutting blocks of tissue from the center of the seared area. Samples should be submitted to the microbiology laboratory in sterile containers with a requisition providing a full explanation of the studies needed. Tissue samples should be processed following standard laboratory methods, and tests should include Gram staining and culture.</para>
    </sect1>
    <sect1 id="ch0035s0020">
      <title>Blood Cultures</title>
      <anchor id="ch0035s0020a0001"/>
      <anchor id="ch0035s0020a0002"/>
      <para id="ch0035s0020p0001">Detection of bacteria and fungi circulating in the bloodstream is a major function of the microbiology laboratory (<link linkend="ch0035s0035s0001li0046">46</link>, <link linkend="ch0035s0035s0001li0047">47</link>). A very important factor in obtaining optimal samples is reducing the potential for contamination by thorough disinfection of the skin surface. An appropriate goal for the blood culture contamination rate is ≤3%, though with implementation of all recommended best practices, a 1% contamination rate should be achievable (<link linkend="ch0035s0035s0001li0048">48</link>). Blood draws through an indwelling intravenous line should generally be avoided, as blood obtained in this way is more than twice as likely to contain a surface organism contaminant as is blood obtained through a peripheral skin site (<link linkend="ch0035s0035s0001li0049">49</link>). As many as 26% of all positive blood cultures are likely to represent contamination and are associated with unnecessary expense, increased length of hospitalization, and dangers of antimicrobial misuse (<link linkend="ch0035s0035s0001li0049">49</link>). Common contaminants include coagulase-negative staphylococci, <emphasis>Micrococcus</emphasis> spp., <emphasis>Corynebacterium</emphasis> spp., <emphasis>Bacillus</emphasis> spp., viridans group streptococci, and <emphasis>Cutibacterium acnes</emphasis> (<link linkend="ch0035s0035s0001li0048">48</link>). In general, single cultures positive for these bacteria reflect contamination. Multiple, separate cultures growing the same strain of these organisms are more likely to indicate a clinically significant bacteremia. Careful site cleansing, using either chlorhexidine-alcohol or iodine tincture, is critical to avoid contaminants (<link linkend="ch0035s0035s0001li0050">50</link>, <link linkend="ch0035s0035s0001li0051">51</link>). All skin disinfectants are activated as they go from wet to dry on the skin surface, so a waiting period of 30 s (chlorhexidine and iodine tincture) is necessary before the needle is inserted. New products are now available that allow diversion and discard of the first few milliliters of blood, which are likely to contain skin contaminants, but more data are needed to support the recommendation that a discard is needed (<link linkend="ch0035s0035s0001li0048">48</link>).</para>
      <para id="ch0035s0020p0002">Another important factor to aid the interpretation of blood culture results is obtaining two separate blood culture sets from two separate sites. Skin commensals involved in true sepsis should be recovered from both sets. Most hospital laboratories have a standard policy that blood culture orders always involve obtaining blood from two separate sites, each inoculating at least two separate bottles. Recovery of all organisms, obligate anaerobes as well as most aerobic bacteria, is enhanced if two types of medium are used. Most often, laboratories choose one aerobic and one anaerobic broth bottle (composing 1 blood culture set). For children, an anaerobic broth bottle is usually not employed unless the patient is at risk for anaerobic septicemia (<link linkend="ch0035s0035s0001li0052">52</link>). Total volume of blood cultured is the major factor for identifying true-positive patients. For an adult, the most sensitive recovery requires at least 40 ml of blood (2 blood culture sets) (<link linkend="ch0035s0035s0001li0053">53</link>). This is a small percentage of total blood volume. Yields from 20 ml and 30 ml of blood were 29.8% and 47.2% greater, respectively, than those from 10 ml of blood; yields from 40 ml were 7.2% greater than those from 30 ml (<link linkend="ch0035s0035s0001li0053">53</link>). <link linkend="ch0035s0020a0003">Table 6</link> shows recommended blood culture volumes for pediatric patients, based on the weight of the patient and the corresponding percentage of the patient’s total blood volume (<link linkend="ch0035s0035s0001li0004">4</link>). Blood should be collected as quickly as possible after the culture is ordered and before antibiotics are given. In most cases, timing of the blood culture with respect to the maximum temperature recorded for the patient during a febrile episode is less important than total volume cultured (<link linkend="ch0035s0035s0001li0054">54</link>).</para>
      <para id="ch0035s0020p0003">For automated blood culture systems, the standard 5-day protocol is sufficient to recover all the usual pathogens and some unusual ones, such as the HACEK organisms (<emphasis>Haemophilus</emphasis> spp. <emphasis>Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens</emphasis>, and <emphasis>Kingella</emphasis> spp.), and holding bottles for additional incubation time only increases the numbers of contaminants recovered (<link linkend="ch0035s0035s0001li0055">55</link>, <link linkend="ch0035s0035s0001li0056">56</link>). Sodium polyanethol sulfonate, used in all blood culture systems as an anticoagulant, may be inhibitory to <emphasis>N. meningitidis, N. gonorrhoeae, Peptostreptococcus anaerobius, Streptobacillus moniliformis</emphasis>, and <emphasis>Gardnerella vaginalis</emphasis>, but the collection of an appropriate ratio of blood to broth volume dilutes sodium polyanethol sulfonate, thereby helping to reduce the inhibitory effect (<link linkend="ch0035s0035s0001li0057">57</link>). In addition, if fungemia due to yeast is suspected, inoculation of blood in standard aerobic blood culture bottle is usually sufficient (see <ulink url="ch0139#ch0139s0001">chapter 118</ulink>, Specimen Collection, Transport and Processing: Mycology). Positive blood culture bottles are evaluated initially by examining a Gram-stained smear of the broth. The report should include a description of the bacterial morphology and the Gram stain reaction. Specimens in positive blood culture bottles should be subcultured to media based on the organism seen in the Gram-stained smear. In general, this should include sheep blood agar, chocolate agar, MacConkey agar, and Columbia nalidixic acid agar plates, since 5 to 10% of all bacteremias are polymicrobial. Anaerobic media and culture conditions should be used if the morphology of the organism seen in the Gram-stained smear is suggestive of an anaerobic bacterium or if the organism is recovered from an anaerobic culture bottle only. If a positively flagged bottle shows no organisms on Gram stain, a second smear should be prepared and stained using acridine orange, a DNA stain (<link linkend="ch0035s0035s0001li0058">58</link>). If organisms are present, even if they have damaged or no cell walls, they will stain bright orange and can be recognized more easily.</para>
      <table id="ch0035s0020t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0020a0003"/><link linkend="ch0035s0003a0015">TABLE 6</link></phrase></emphasis> Recommended blood volumes for culture for pediatric patients<superscript><link linkend="ch0035s0020a0006"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0020a0004"/>
</title>
        
        <tgroup cols="5">
          <tbody>
            <row>
              <entry>Patient wt [kg]</entry>
              <entry><phrase role="center">Recommended blood vol (ml) per culture set</phrase>
              </entry>
              <entry><phrase role="center">No. of blood culture sets<superscript><link linkend="ch0035s0020a0007"><emphasis>b</emphasis></link></superscript></phrase>
                <anchor id="ch0035s0020a0005"/>
              </entry>
              <entry><phrase role="center">Total blood vol (ml) drawn</phrase>
              </entry>
              <entry><phrase role="center">% of patient’s total blood vol (ml)</phrase>
              </entry>
            </row>
            <row>
              <entry>≤1</entry>
              <entry><phrase role="center">2</phrase>
              </entry>
              <entry><phrase role="center">1</phrase>
              </entry>
              <entry><phrase role="center">2</phrase>
              </entry>
              <entry><phrase role="center">4</phrase>
              </entry>
            </row>
            <row>
              <entry>1.1–2</entry>
              <entry><phrase role="center">2</phrase>
              </entry>
              <entry><phrase role="center">2</phrase>
              </entry>
              <entry><phrase role="center">4</phrase>
              </entry>
              <entry><phrase role="center">4</phrase>
              </entry>
            </row>
            <row>
              <entry>2.1–12.7</entry>
              <entry><phrase role="center">4 (set 1); 2 (set 2)</phrase>
              </entry>
              <entry><phrase role="center">2</phrase>
              </entry>
              <entry><phrase role="center">6</phrase>
              </entry>
              <entry><phrase role="center">3</phrase>
              </entry>
            </row>
            <row>
              <entry>12.8–36.3</entry>
              <entry><phrase role="center">10</phrase>
              </entry>
              <entry><phrase role="center">2</phrase>
              </entry>
              <entry><phrase role="center">20</phrase>
              </entry>
              <entry><phrase role="center">2.5</phrase>
              </entry>
            </row>
            <row>
              <entry>≥36.3</entry>
              <entry><phrase role="center">20–30</phrase>
              </entry>
              <entry><phrase role="center">2</phrase>
              </entry>
              <entry><phrase role="center">40–60</phrase>
              </entry>
              <entry><phrase role="center">1.8–2.7</phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><link linkend="ch0035s0020a0004"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0020a0006"/>Adapted from reference <link linkend="ch0035s0035s0001li0004">4</link>.</para>
      <para role="table-footnote"><superscript><link linkend="ch0035s0020a0005"><emphasis>b</emphasis></link></superscript><anchor id="ch0035s0020a0007"/>Aerobic bottle (pediatric bottles are used in some centers).</para>
      <para id="ch0035s0020p0004">Rapid sample preparation and improvements in matrix-assisted laser desorption ionization–time of flight mass spectrometry databases have made identification of organisms from positive blood cultures by mass spectrometry more feasible for clinical laboratories (<link linkend="ch0035s0035s0001li0059">59</link>, <link linkend="ch0035s0035s0001li0060">60</link>). In addition, a number of nucleic acid amplification and/or hybridization assays, performed directly from positive blood cultures, are now commercially available. These assays dramatically shorten the time to identification result reporting and have been shown to decrease time to effective antibiotic therapy, length of stay, and hospital costs (<link linkend="ch0035s0035s0001li0061">61</link>, <link linkend="ch0035s0035s0001li0062">62</link>). Details on these rapid molecular and proteomic methods are reviewed in <ulink url="ch0020#ch0020s0001">chapter 5</ulink>, Laboratory Detection of Bacteremia and Fungemia.</para>
      <anchor id="ch0035s0020a0008"/>
      <beginpage pagenum="375"/>
      <sect2 id="ch0035s0020s0001">
        <title>Role of Follow-up Blood Cultures after Initial Positivity</title>
        <anchor id="ch0035s0020s0001a0001"/>
        <anchor id="ch0035s0020s0001a0002"/>
        <para id="ch0035s0020s0001p0001">The Infectious Disease Society of America guidelines for the treatment of methicillin-resistant<emphasis>S. aureus</emphasis> (MRSA) bacteremia recommend repeating blood cultures to document clearance of infection 2 to 4 days after the initial positive culture (<link linkend="ch0035s0035s0001li0063">63</link>). A single set of surveillance blood cultures is adequate to document clearance in individuals with <emphasis>S. aureus</emphasis> bacteremia. <emphasis>Staphylococcus lugdunensis</emphasis> is equally virulent and associated with infective endocarditis, so a similar approach is reasonable. Patients with Gram-negative bacteremia rarely have persistent bacteremia when source control is adequate and do not require routine follow-up blood cultures (<link linkend="ch0035s0035s0001li0064">64</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0035s0021">
      <title>Central Venous Catheters</title>
      <anchor id="ch0035s0021a0001"/>
      <anchor id="ch0035s0021a0002"/>
      <para id="ch0035s0021p0001">Traditional methods for culture of intravascular catheter tips are controversial for determining the source of a bacteremia, because by the time the culture result is obtained, the catheter (if it was the source) has already been removed (<link linkend="ch0035s0035s0001li0065">65</link>). The most common technique used to culture the exterior of the intravascular portion of a catheter is the semiquantitative method in which the 5-cm distal portion of the catheter is rolled across a blood agar plate four times (<link linkend="ch0035s0035s0001li0066">66</link>). Growth of ≥15 colonies is considered significant, i.e., implicating the catheter tip as the likely source of a bacteremia caused by the same organism simultaneously isolated from blood cultures. Interpretation of clinical importance is not possible without an accompanying positive blood culture. For suspected catheter exit site infection, freshly expressed pus can be aspirated for culture.</para>
      <para id="ch0035s0021p0002">Some laboratories have adopted methods for determining if the indwelling intravenous (usually central) line is the source of a bacteremia without removing the line. One method requires a 3-fold-higher quantity of organisms recovered in the blood obtained through the line than that obtained peripherally. However, determining CFU is labor-intensive, so an alternative method uses the differential time to positivity, where a blood culture drawn from a central line signals positive at least 2 h earlier than the peripheral blood culture (<link linkend="ch0035s0035s0001li0066">66</link>). Neither catheter tip surface cultures nor differential time-to-positivity methods appear to work well in predicting catheter-related candidemia (<link linkend="ch0035s0035s0001li0067">67</link>).</para>
    </sect1>
    <sect1 id="ch0035s0022">
      <title>Cerebrospinal Fluid</title>
      <anchor id="ch0035s0022a0001"/>
      <anchor id="ch0035s0022a0002"/>
      <para id="ch0035s0022p0001">CSF is collected by lumbar puncture for the diagnosis of meningitis (<anchor id="ch0035s0022a0003"/><link linkend="ch0035s0023a0005">Table 7</link>). As with all clinical specimens, even those collected from a presumably sterile site, growth of contaminants occasionally does occur. The first tube collected by lumbar puncture, which is most likely to have a few skin organisms introduced during the procedure, should be used for chemistry tests; the second or third tube, which is less likely to contain the rare contaminant, should be used for microbiology studies (<link linkend="ch0035s0035s0001li0068">68</link>).</para>
      <para id="ch0035s0022p0002">Although bacterial staining and culture can be performed with as little as 0.5 ml of CSF, larger volumes are preferred. If the specimen volume is less than required for multiple requested tests, providers should be contacted to prioritize testing. Specimens should be delivered rapidly in a sterile container maintained at room temperature. All smears should be prepared by cytocentrifugation, and cultures should be inoculated with 0.5 ml of CSF (<link linkend="ch0035s0035s0001li0069">69</link>). Media are inoculated in accordance with recommendations in <link linkend="ch0035s0016a0008">Table 5</link>. Larger CSF volumes, 7 to 10 ml, are recommended for recovery of <emphasis>Mycobacterium tuberculosis</emphasis>, although the yield may still be low (<link linkend="ch0035s0035s0001li0070">70</link>). As a result, the use of nucleic acid tests is recommended by the World Health Organization for diagnosis of tuberculous meningitis, although none of these tests are approved by the FDA for this purpose (<link linkend="ch0035s0035s0001li0071">71</link>, <link linkend="ch0035s0035s0001li0072">72</link>). Anaerobes are rarely found in CSF, even in cases of mixed anaerobic abscess of brain tissue. <emphasis>C. acnes</emphasis> may be the cause of infection in patients with indwelling CSF shunts; hence the recommendation to perform anaerobic culture on shunt specimens (<link linkend="ch0035s0035s0001li0073">73</link>, <link linkend="ch0035s0035s0001li0074">74</link>).</para>
      <para id="ch0035s0022p0003">Smears should be Gram stained and results reported to the physician immediately. Results should include a description and semiquantitative enumeration of polymorphonuclear inflammatory cells and bacterial morphology. Because of low sensitivity and lack of effect on the care and management of patients, direct antigen tests for bacteria are not recommended. Note that cryptococcal antigen tests are still valuable. A multiplex PCR panel for the simultaneous detection of 14 bacterial, viral, and yeast pathogens in about an hour from 200 μl of CSF is commercially available (FilmArray ME panel; BioFire Diagnostics, Salt Lake City, UT), but molecular detection should not replace bacterial culture (<link linkend="ch0035s0035s0001li0075">75</link>).</para>
    </sect1>
    <sect1 id="ch0035s0023">
      <title>Eyes</title>
      <anchor id="ch0035s0023a0001"/>
      <anchor id="ch0035s0023a0002"/>
      <para id="ch0035s0023p0001">Several types of specimens may be collected for the microbiological analysis of eye infections, including conjunctival scrapings obtained with a swab or sterile spatula for the diagnosis of conjunctivitis, corneal scrapings collected with a sterile spatula for the diagnosis of keratitis, vitreous fluid collected by aspiration for the diagnosis of endophthalmitis, and fluid material collected by aspiration or tissue biopsy for the diagnosis of periorbital cellulitis. Pathogenic bacteria potentially present in these anatomic sites are listed in<link linkend="ch0035s0023a0005">Table 7</link>. Because the volume of specimen collected from corneal scrapings and vitreous fluid aspiration is very small, direct inoculation of agar culture plates and preparation of smears in the clinic or at the bedside are recommended. A close working association is needed between the laboratory and ophthalmologist to ensure a supply of appropriate culture media, correct technique for inoculation of media, and rapid transport of plates and smears to the laboratory. Media should be inoculated by rubbing the specimen onto a small area of the agar plates or wiping the material from the scraping off the spatula gently onto the agar surface, sometimes in the shapes of little Cs. Plates are often labeled OD (right eye) or OS (left eye) and should be placed directly in the incubator without cross-streaking by laboratory personnel.</para>
      <anchor id="ch0035s0023a0003"/>
      <beginpage pagenum="376"/>
      <anchor id="ch0035s0023a0004"/>
      <beginpage pagenum="377"/>
      <table id="ch0035s0023t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0035s0023a0005"/><link linkend="ch0035s0022a0003">TABLE 7</link></phrase></emphasis> Usual etiologies of selected infectious disease syndromes
</title>
        
        <tgroup cols="2">
          <tbody>
            <row>
              <entry>Disease</entry>
              <entry>Etiologies</entry>
            </row>
            <row>
              <entry>Central nervous system infection</entry>
              <entry/>
            </row>
            <row>
              <entry>Acute meningitis, neutrophilic pleocytosis</entry>
              <entry><emphasis>S. pneumoniae, N. meningitidis, Listeria monocytogenes, Streptococcus agalactiae, H. influenzae</emphasis>
              </entry>
            </row>
            <row>
              <entry>Acute meningitis, CSF shunt related</entry>
              <entry>Coagulase-negative staphylococci,<emphasis>S. aureus, Cutibacterium</emphasis> spp., Gram-negative enteric rods (e.g., <emphasis>E. coli</emphasis> and <emphasis>Klebsiella</emphasis> spp.), Gram-negative nonfermenting rods (e.g., <emphasis>P. aeruginosa</emphasis> and <emphasis>Acinetobacter</emphasis> spp.)</entry>
            </row>
            <row>
              <entry>Chronic meningitis, predominantly lymphocytic pleocytosis</entry>
              <entry><emphasis>Nocardia</emphasis> spp., <emphasis>Brucella</emphasis> spp., <emphasis>Leptospira interrogans, M. tuberculosis, T. pa</emphasis><emphasis>llidum, Borrelia burgdorferi</emphasis></entry>
            </row>
            <row>
              <entry>Gastrointestinal tract infection</entry>
              <entry/>
            </row>
            <row>
              <entry>Infectious diarrhea<superscript><link linkend="ch0035s0023a0010"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0023a0006"/></entry>
              <entry><emphasis>Salmonella</emphasis> serotypes; <emphasis>Shigella</emphasis> spp.; <emphasis>C. jejuni</emphasis>-<emphasis>C. coli</emphasis>; <emphasis>Campylobacter</emphasis> spp. (other); STEC; <emphasis>C. difficile</emphasis>; <emphasis>Vibrio</emphasis> spp.; <emphasis>Aeromonas</emphasis> spp.; <emphasis>P. shigelloid</emphasis><emphasis>es</emphasis>; <emphasis>Y. enterocolitica</emphasis>; <emphasis>E. coli</emphasis> toxigenic, invasive, and effacing strains; <emphasis>L. monocytogenes</emphasis>; <emphasis>Clostridium perfringens</emphasis>; <emphasis>Bacillus cereus</emphasis></entry>
            </row>
            <row>
              <entry>Ingestion of preformed toxin<superscript><link linkend="ch0035s0023a0011"><emphasis>b</emphasis></link></superscript><anchor id="ch0035s0023a0007"/></entry>
              <entry><emphasis>S. aureus, B. cereus</emphasis>
              </entry>
            </row>
            <row>
              <entry>Gastritis, gastric and duodenal ulcers</entry>
              <entry><emphasis>H. pylori</emphasis>
              </entry>
            </row>
            <row>
              <entry>Genital tract infection</entry>
              <entry/>
            </row>
            <row>
              <entry>Ulcers</entry>
              <entry><emphasis>T. pallidum, H. ducreyi, C. trachomatis</emphasis> (lymphogranuloma venereum), <emphasis>K. granulomatis</emphasis></entry>
            </row>
            <row>
              <entry>Urethritis</entry>
              <entry><emphasis>N. gonorrhoeae, C. trachomatis, M. genitalium, Ureaplasma urealyticum, T. vaginalis</emphasis>
              </entry>
            </row>
            <row>
              <entry>Vulvovaginitis</entry>
              <entry><emphasis>N. gonorrhoeae</emphasis> and <emphasis>C. trachomatis</emphasis> in prepubescent girls</entry>
            </row>
            <row>
              <entry>BV</entry>
              <entry>Overgrowth of vaginal biota with anaerobic bacteria</entry>
            </row>
            <row>
              <entry>Cervicitis</entry>
              <entry><emphasis>N. gonorrhoeae, C. trachomatis</emphasis>
              </entry>
            </row>
            <row>
              <entry>Endometritis</entry>
              <entry><emphasis>Enterobacteriaceae</emphasis>, streptococci (groups A and B), enterococci, mixed anaerobic genera</entry>
            </row>
            <row>
              <entry>Salpingitis, oophoritis</entry>
              <entry><emphasis>N. gonorrhoeae, C. trachomatis</emphasis>, mixed aerobic and anaerobic microbiota</entry>
            </row>
            <row>
              <entry>Pelvic abscess</entry>
              <entry>Mixed aerobic and anaerobic microbiota</entry>
            </row>
            <row>
              <entry>Epididymitis</entry>
              <entry><emphasis>N. gonorrhoeae, C. trachomatis, Enterobacteriaceae, P. aeruginosa</emphasis>, various Gram-positive cocci</entry>
            </row>
            <row>
              <entry>Ocular infections</entry>
              <entry/>
            </row>
            <row>
              <entry>Conjunctivitis</entry>
              <entry><emphasis>S. pneumoniae, S. aureus, H. influenzae, N. meningitidis, N. gonorrhoeae, C. trachomatis</emphasis> (inclusion conjunctivitis and trachoma), others<superscript><emphasis><anchor id="ch0035s0023a0008"/><link linkend="ch0035s0023a0012">c</link></emphasis></superscript></entry>
            </row>
            <row>
              <entry>Keratitis</entry>
              <entry><emphasis>S. aureus, S. pneumoniae, P. aeruginosa</emphasis>, enterococci, <emphasis>S. pyogenes</emphasis> (group A), <emphasis>Enterobacteriaceae, Pasteurella multocida</emphasis>, coagulase-negative staphylococci (postsurgery), <emphasis>C. acnes</emphasis> (especially postsurgery), rapidly growing mycobacteria, others<emphasis role="underline"><anchor id="ch0035s0023a0009"/><link linkend="ch0035s0023a0013">d</link></emphasis></entry>
            </row>
            <row>
              <entry>Endophthalmitis</entry>
              <entry><emphasis>S. aureus, P. aeruginosa, C. acnes, S. pneumoniae, N. meningitidis, Nocardia</emphasis> spp.</entry>
            </row>
            <row>
              <entry>Periorbital cellulitis</entry>
              <entry><emphasis>S. aureus, S. pyogenes, S. pneumoniae, H. influenzae, Clostridium</emphasis> spp.</entry>
            </row>
            <row>
              <entry>Otitis</entry>
              <entry/>
            </row>
            <row>
              <entry>Otitis externa</entry>
              <entry><emphasis>S. aureus, S. pyogenes, P. aeruginosa</emphasis>,</entry>
            </row>
            <row>
              <entry>Otitis media</entry>
              <entry><emphasis>S. pneumoniae, H. influenzae, Moraxella catarrhalis, S. aureus</emphasis>, rare pathogens: Gram-negative rods, anaerobes, aerobic actinomycetes</entry>
            </row>
            <row>
              <entry>Respiratory tract infection</entry>
              <entry/>
            </row>
            <row>
              <entry>Tracheitis, intubated patient</entry>
              <entry><emphasis>Enterobacteriaceae, S. aureus, P. aeruginosa</emphasis>, other nonfermenting Gram-negative rods</entry>
            </row>
            <row>
              <entry>Bronchitis, community acquired</entry>
              <entry><emphasis>S. pneumoniae, H. influenzae</emphasis> (rarely, other <emphasis>Haemophilus</emphasis> species), <emphasis>M. catarrhalis, S. aureus, Chlamydia pneumoniae, M. pneumoniae, B. pertussis, S. pyogenes</emphasis>; less commonly, same as hospital acquired</entry>
            </row>
            <row>
              <entry>Bronchitis, hospital acquired</entry>
              <entry><emphasis>Enterobacteriaceae, S. aureus, P. aeruginosa</emphasis>, other nonfermenting Gram-negative rods; less commonly, same as community acquired</entry>
            </row>
            <row>
              <entry>Pneumonia, community acquired</entry>
              <entry><emphasis>S. pneumoniae, H. influenzae, M. catarrhalis, C. pneumoniae, M. pneumoniae, L. pneumophila, Nocardia</emphasis> spp., <emphasis>M. tuberculosis, S. aureus, Klebsiella pneumoniae</emphasis>, anaerobes (aspiration); less commonly, same as hospital acquired</entry>
            </row>
            <row>
              <entry>Pneumonia, hospital acquired</entry>
              <entry><emphasis>Enterobacteriaceae, S. aureus, P. aeruginosa, L. pneumophila</emphasis>, other nonfermenting Gram-negative rods, aspiration (anaerobes); less commonly, same as community acquired</entry>
            </row>
            <row>
              <entry>Lung abscess</entry>
              <entry><emphasis>S. aureus, K. pneumoniae, P. aeruginosa, S. pyogenes</emphasis>, anaerobes (aspiration pneumonia), <emphasis>Nocardia</emphasis> spp.</entry>
            </row>
            <row>
              <entry>Empyema</entry>
              <entry><emphasis>S. pneumoniae</emphasis>; anaerobes; viridans group streptococci, especially <emphasis>Streptococcus anginosus</emphasis> group; <emphasis>S. aureus</emphasis>; <emphasis>S. pyogenes</emphasis>; Gram-negative rods</entry>
            </row>
            <row>
              <entry>Osteomyelitis</entry>
              <entry><emphasis>S. aureus, M. tuberculosis, P. aeruginosa</emphasis>, other organisms depending on site</entry>
            </row>
            <row>
              <entry>Urinary tract infection</entry>
              <entry/>
            </row>
            <row>
              <entry>Prostatitis</entry>
              <entry><emphasis>Enterobacteriaceae, P. aeruginosa</emphasis>, enterococci</entry>
            </row>
            <row>
              <entry>Urethral syndrome</entry>
              <entry>Same as cystitis, but in lower numbers;<emphasis>C. trachomatis</emphasis> and <emphasis>N. gonorrhoeae</emphasis></entry>
            </row>
            <row>
              <entry>Cystitis</entry>
              <entry><emphasis>Enterobacteriaceae</emphasis>, especially <emphasis>E. coli</emphasis>; enterococci; <emphasis>Staphylococcus saprophyticus</emphasis> (women of childbearing age); nonfermenting Gram-negative rods; <emphasis>Corynebacterium urealyticum</emphasis> (patients with underlying urinary tract pathology)</entry>
            </row>
            <row>
              <entry>Pyelonephritis</entry>
              <entry><emphasis>Enterobacteriaceae</emphasis>; enterococci; agents of bacteremia (descending infection), e.g., <emphasis>S. aureus</emphasis></entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><link linkend="ch0035s0023a0006"><emphasis>a</emphasis></link></superscript><anchor id="ch0035s0023a0010"/>Disease caused by ingestion of bacteria followed by tissue invasion, toxin production, or other pathogenic mechanism.</para>
      <para role="table-footnote"><superscript><link linkend="ch0035s0023a0007"><emphasis>b</emphasis></link></superscript><anchor id="ch0035s0023a0011"/>Disease caused by ingestion of preformed toxin.</para>
      <para role="table-footnote"><superscript><link linkend="ch0035s0023a0008"><emphasis>c</emphasis></link></superscript><anchor id="ch0035s0023a0012"/><emphasis>C. diphtheriae, M. tuberculosis, F. tularensis, T. pallidum, B. henselae</emphasis> (cat scratch), <emphasis>P. multocida, Bacillus thuringiensis</emphasis>, and <emphasis>Moraxella lacunata</emphasis>.</para>
      <para role="table-footnote"><superscript><link linkend="ch0035s0023a0009"><emphasis>d</emphasis></link></superscript><anchor id="ch0035s0023a0013"/><emphasis>T. pallidum, N. gonorrhoeae, Moraxella</emphasis> spp., <emphasis>C. diphtheriae, Bacillus</emphasis> spp., anaerobes, and nontuberculous mycobacteria.</para>
      <para id="ch0035s0023p0002">Media needed for the detection of usual pathogens include chocolate agar for fastidious bacteria and most fungi (<link linkend="ch0035s0016a0008">Table 5</link>) (<link linkend="ch0035s0035s0001li0076">76</link>). Cultures for other microorganisms (some fungi, viruses, mycobacteria, etc.) should be inoculated if deemed appropriate by the ophthalmologist and microbiologist and specifically ordered. Nucleic acid amplification tests (NAATs) are the test of choice for detection of <emphasis>C. trachomatis</emphasis> in conjunctival scrapings for the diagnosis of inclusion conjunctivitis or trachoma, but they require in-house verification, as none of the commercially available assays are FDA approved for ocular specimens (<link linkend="ch0035s0035s0001li0077">77</link>). If a <emphasis>C. trachomatis</emphasis> NAAT is not available for ocular specimens, conjunctival scrapings and secretions should be transported in viral/chlamydia transport medium (such as M4, M5, or M6) for culture (see <ulink url="ch0083#ch0083s0001">chapter 66</ulink>, Chlamydia).</para>
    </sect1>
    <sect1 id="ch0035s0024">
      <title>Ears</title>
      <anchor id="ch0035s0024a0001"/>
      <anchor id="ch0035s0024a0002"/>
      <para id="ch0035s0024p0001">Nasopharyngeal culture results are poor predictors of middle ear pathogens and should not be used for that purpose (<link linkend="ch0035s0035s0001li0078">78</link>). Two types of ear specimens are received most commonly by the laboratory: swab specimens for the diagnosis of otitis externa and middle ear fluid specimens for the diagnosis of otitis media (<link linkend="ch0035s0023a0005">Table 7</link>). Potential pathogens at these two sites differ (<link linkend="ch0035s0035s0001li0079">79</link>). Anaerobic culture, if ordered for middle ear fluid, should be performed on properly collected aspirates that are transported in anaerobic transport vials. Direct examination of Gram-stained smears of middle ear fluid is helpful and is recommended with all culture requests.</para>
    </sect1>
    <sect1 id="ch0035s0025">
      <title>Gastrointestinal Tract</title>
      <anchor id="ch0035s0025a0001"/>
      <anchor id="ch0035s0025a0002"/>
      <para id="ch0035s0025p0001">Stool specimens are frequently submitted to the microbiology laboratory to determine the etiological agent of infectious diarrhea. In fact, most diarrhea is caused not by bacteria but by viruses, parasites, immune-related disease, or other factors. Feces submitted for detection of enteric pathogens should be collected in a clean container with a tight lid and should not be contaminated with urine, barium, or toilet paper. Because intestinal pathogens can be killed by the metabolism of other fecal bacteria rapidly acidifying the specimen, specimens should be transferred to Cary-Blair transport medium soon after collection.<emphasis>Shigella</emphasis> is the most labile, often becoming unculturable within 30 min of collection. For <emphasis>Vibrio cholerae</emphasis>, other transport media, such as alkaline peptone water, are preferred. Rectal swabs have been shown to have sensitivity for fecal pathogen detection similar to that of stool for both culture and molecular detection (<link linkend="ch0035s0035s0001li0016">16</link>, <link linkend="ch0035s0035s0001li0017">17</link>).</para>
      <para id="ch0035s0025p0002">Use of a fecal collection and transport device consisting of a flocked swab in 2 ml of modified Cary-Blair medium can also be considered (<link linkend="ch0035s0035s0001li0080">80</link>). The use of culture-independent diagnostic tests, such as NAATs, for a panel of stool pathogens has become more common (<link linkend="ch0035s0035s0001li0081">81</link>).</para>
      <para id="ch0035s0025p0003">It should be standard practice in all laboratories to evaluate the appropriateness of stool culture or NAAT requests. Hospitalized patients who did not enter the hospital with diarrhea are unlikely to develop bacterial enterocolitis caused by bacterial agents other than<emphasis>C. difficile</emphasis> (<link linkend="ch0035s0035s0001li0082">82</link>–<link linkend="ch0035s0035s0001li0084">84</link>). For this reason, stool samples from patients who have been hospitalized for more than 3 days should be rejected. <emphasis>C. difficile</emphasis> testing in the hospital setting should be performed only on liquid stools and in conjunction with infection control policies. The goal is to maximize detection of <emphasis>C. difficile</emphasis> infection and minimize detection of colonized individuals. <emphasis>C. difficile</emphasis> infection is rapidly expanding as a community-acquired disease, and requests for <emphasis>C. difficile</emphasis> infection testing on liquid stools should not be rejected when ordered for outpatients (<link linkend="ch0035s0035s0001li0084">84</link>). After an initial negative NAAT for <emphasis>C. difficile</emphasis>, however, repeat testing is not warranted, and use of NAATs for test of cure is inappropriate (<link linkend="ch0035s0035s0001li0084">84</link>) (see <ulink url="ch0073#ch0073s0001">chapter 56</ulink>, <emphasis>Clostridium</emphasis> and <emphasis>Clostridioides</emphasis>).</para>
      <para id="ch0035s0025p0004">Numerous studies have shown that neither fecal leukocyte examination nor lactoferrin is useful for differentiating inflammatory from noninflammatory diarrhea (<link linkend="ch0035s0035s0001li0085">85</link>). For these reasons, use of any tests for fecal leukocytes should not be relied on to rule in or rule out acute infectious diarrhea. Usual gastrointestinal pathogens are listed in <link linkend="ch0035s0023a0005">Table 7</link>, and selective and differential media used to detect <emphasis>Salmonella, Shigella</emphasis> and <emphasis>Campylobacter</emphasis> spp. are listed in <link linkend="ch0035s0016a0008">Table 5</link>. Media for isolation of <emphasis>Campylobacter</emphasis> spp. are incubated at 42°C in a microaerophilic atmosphere of nitrogen (85%), carbon dioxide (10%), and oxygen (5%) for up to 3 days. All other agar plates should be incubated in air at 35 to 37°C for 2 days before being reported as negative. Testing for less frequently encountered pathogens should be considered when epidemiological factors suggest an increased likelihood. This may require periodic surveys of one’s community to establish which pathogens are most common, especially when the addition of selective medium or a toxin assay for the routine detection of campylobacters other than <emphasis>Campylobacter jejuni</emphasis> or <emphasis>Campylobacter coli, Vibrio</emphasis> spp., and <emphasis>Yersinia enterocolitica</emphasis> is being considered. Rapid enzyme immunoassay (EIA) methods for detection of surface antigens of some <emphasis>Campylobacter</emphasis> species have been evaluated and shown to be sensitive but have poor positive predictive value and should not be used as stand-alone tests (<link linkend="ch0035s0035s0001li0082">82</link>). Culture-independent diagnostic tests, such as NAATs, demonstrate excellent sensitivity and specificity for detection of <emphasis>Campylobacter</emphasis> spp. and offer the advantage of simultaneous and rapid detection of other enteric pathogens (<link linkend="ch0035s0035s0001li0081">81</link>).</para>
      <anchor id="ch0035s0025a0003"/>
      <beginpage pagenum="378"/>
      <sect2 id="ch0035s0025s0001">
        <title>Shiga-Toxin Producing Escherichia coli</title>
        <anchor id="ch0035s0025s0001a0001"/>
        <anchor id="ch0035s0025s0001a0002"/>
        <para id="ch0035s0025s0001p0001">Shiga toxin-producing<emphasis>Escherichia coli</emphasis> (STEC) causes hemorrhagic colitis and hemolytic-uremic syndrome. The prevalence of STEC varies in different parts of the United States and the rest of the world. In addition to <emphasis>E. coli</emphasis> O157:H7, there are many other serotypes of STEC. In fact, in the United States, ~50% of STEC organisms are not serotype O157:H7 (<link linkend="ch0035s0035s0001li0086">86</link>, <link linkend="ch0035s0035s0001li0087">87</link>). Shiga toxin EIAs and NAAT panels detect all serotypes. Routine culture of all stools on a selective medium and use of either an EIA or NAAT on an enriched broth (either Gram-negative broth or MacConkey broth) for detection of STEC have been recommended by the CDC (<link linkend="ch0035s0035s0001li0088">88</link>). Recommendations from both the CDC and American Public Health Laboratory for universal STEC testing contain strategies for referral of non-O157 strains for further testing by public health laboratories (<link linkend="ch0035s0035s0001li0089">89</link>). A downloadable guide is available from the American Public Health Laboratory site (<ulink url="http://www.aphl.org/AboutAPHL/publications/Documents/FS_2012April_Guidance-for-PHLs-Isolation-and-Characterization-of-Shiga-Toxin-Producing-Escherichia-coli-STEC-from-Clinical.pdf">http://www.aphl.org/AboutAPHL/publications/Documents/FS_2012April_Guidance-for-PHLs-Isolation-and-Characterization-of-Shiga-Toxin-Producing-Escherichia-coli-STEC-from-Clinical.pdf</ulink>). Sorbitol-MacConkey agar, cefixime-tellurite-sorbitol-MacConkey agar, or a chromogenic agar can be used to detect O157 serotype strains. Non-O157 strains, such as the European outbreak O104 strain, will not be detected using these media (<link linkend="ch0035s0035s0001li0090">90</link>).</para>
      </sect2>
      <sect2 id="ch0035s0025s0002">
        <title>Other Enteric Pathogens</title>
        <anchor id="ch0035s0025s0002a0001"/>
        <anchor id="ch0035s0025s0002a0002"/>
        <para id="ch0035s0025s0002p0001">Routine testing for<emphasis>Vibrio</emphasis> spp., <emphasis>Y. enterocolitica, Aeromonas</emphasis> spp., and <emphasis>Plesiomonas shigelloides</emphasis> should not be performed in some geographic locations, since incidences are so low in most parts of the United States that the routine use of selective media is not justified. Testing should be available in house or through a reference laboratory upon provider request or in certain epidemiological situations. Media used for these enteric pathogens include thiosulfate-citrate-bile salts-sucrose agar for vibrios, cefsulodin-Irgasan-novobiocin agar for <emphasis>Y. enterocolitica</emphasis>, and blood agar or selective blood agar to demonstrate hemolysis and provide a medium for oxidase testing for <emphasis>Aeromonas</emphasis> spp. and <emphasis>P. shigelloides</emphasis> (both oxidase positive) (<link linkend="ch0035s0035s0001li0082">82</link>). All of these enteric pathogens grow on usual media, but detection is enhanced and simplified using specific selective media.</para>
      </sect2>
      <sect2 id="ch0035s0025s0003">
        <title>Detection of VRE, CRE, or Beta-Hemolytic Streptococci in Rectal Specimens</title>
        <anchor id="ch0035s0025s0003a0001"/>
        <anchor id="ch0035s0025s0003a0002"/>
        <para id="ch0035s0025s0003p0001">Identifying carriers of VRE and/or carbapenem-producing carbapenem-resistant<emphasis>Enterobacterales</emphasis> (CP-CRE) for infection control purposes and group A streptococci during investigations of nosocomial outbreaks or for diagnosis of perianal infections in children, respectively, requires collection of a rectal swab specimen (<link linkend="ch0035s0035s0001li0091">91</link>). Carriers of VRE can be identified by culturing rectal swabbed or perirectal swabbed material or by the use of molecular methods. Swab specimens are inoculated to selective enrichment broth, such as Enterococcosel broth with 6 μg of vancomycin/ml, colistin-nalidixic acid blood agar containing 6 μg of vancomycin/ml, or VRE chromogenic agar. Detection of CP-CRE carriage can also be performed using either molecular or culture-based approaches. Culture of CP-CRE often relies on the use of selective screening plates or chromogenic agar, with or without enrichment broth, while a variety of molecular diagnostic approaches have been described (<link linkend="ch0035s0035s0001li0092">92</link>). Additional resources for surveillance of VRE and CP-CRE are available on the CDC website at <ulink url="https://www.cdc.gov/hai/settings/lab/lab_settings.html">https://www.cdc.gov/hai/settings/lab/lab_settings.html</ulink>. Group A streptococci can be isolated by culturing rectal swab specimens on sheep blood agar or selective streptococcal agars.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0035s0026">
      <title>Genital Samples</title>
      <anchor id="ch0035s0026a0001"/>
      <anchor id="ch0035s0026a0002"/>
      <para id="ch0035s0026p0001">Bacterial infections of genital tract sites produce various clinical syndromes, including vulvovaginitis, BV, genital ulcers, urethritis, cervicitis, endometritis, salpingitis, and ovarian abscess in females and urethritis, epididymitis, prostatitis, and genital ulcers in males. These diseases and their etiologies are listed in<link linkend="ch0035s0023a0005">Table 7</link>.</para>
      <sect2 id="ch0035s0026s0001">
        <title>Detection of N. gonorrhoeae and C. trachomatis</title>
        <anchor id="ch0035s0026s0001a0001"/>
        <anchor id="ch0035s0026s0001a0002"/>
        <para id="ch0035s0026s0001p0001">NAAT methods are preferred for detection of<emphasis>N. gonorrhoeae</emphasis> and <emphasis>C. trachomatis</emphasis> in endocervical, vaginal, urethral, and urine specimens. Users must pay close attention to the types of specimens approved for use with each commercial assay. Specimens should be collected using the procedures and devices recommended by the manufacturer. Of note, recent publications using NAATs have highlighted greater prevalence of <emphasis>Trichomonas</emphasis> than chlamydia and gonorrhea in certain patient populations, leading to a growing trend towards simultaneous screening for <emphasis>Trichomonas</emphasis>, chlamydia, and gonorrhea (<link linkend="ch0035s0035s0001li0093">93</link>). In addition, NAATs for <emphasis>Mycoplasma genitalium</emphasis> are also now available and recommended for males with recurrent nongonococcal urethritis and women with recurrent cervicitis (<link linkend="ch0035s0035s0001li0094">94</link>).</para>
        <para id="ch0035s0026s0001p0002">Extragenital screening increases the rate of<emphasis>Chlamydia trachomatis</emphasis> and <emphasis>Neisseria gonorrhoeae</emphasis> detection for both adult and pediatric patients (<link linkend="ch0035s0035s0001li0094">94</link>, <link linkend="ch0035s0035s0001li0095">95</link>). Although eye, pharyngeal, and rectal specimens are not always FDA cleared for testing in the commercial amplification systems, molecular methods are superior to culture (<link linkend="ch0035s0035s0001li0096">96</link>). In addition, due to the high sensitivity of molecular tests, self-collected swabs from both men and women perform at least as well as those collected by health care personnel for <emphasis>C. trachomatis</emphasis> and <emphasis>N. gonorrhoeae</emphasis> (<link linkend="ch0035s0035s0001li0097">97</link>, <link linkend="ch0035s0035s0001li0098">98</link>). In some jurisdictions, culture is still the only acceptable diagnostic procedure for medical legal cases, but due to the low sensitivity of <emphasis>C. trachomatis</emphasis> culture, a NAAT should always be performed for medical decisions (<link linkend="ch0035s0035s0001li0004">4</link>).</para>
        <para id="ch0035s0026s0001p0003">Culture for<emphasis>N. gonorrhoeae</emphasis> is optimal when the specimen is directly inoculated in the physician’s office to a selective medium, such as modified Thayer-Martin medium, and incubated immediately, followed by transport to the clinical laboratory. Alternatively, swab specimens should be placed in a transport system containing Stuart’s or Amies medium and delivered to the microbiology laboratory as quickly as possible. Cotton swabs should be avoided, because they may be toxic to <emphasis>N. gonorrhoeae</emphasis>. Some newer transport products have shown improved ability to retain the viability of <emphasis>N. gonorrhoeae</emphasis> (<link linkend="ch0035s0035s0001li0099">99</link>, <link linkend="ch0035s0035s0001li0100">100</link>). Specimens for <emphasis>N. gonorrhoeae</emphasis> culture should be held at refrigeration temperature during transport (<link linkend="ch0035s0035s0001li0101">101</link>).</para>
        <anchor id="ch0035s0026s0001a0003"/>
        <beginpage pagenum="379"/>
      </sect2>
      <sect2 id="ch0035s0026s0002">
        <title>Bacterial vaginosis (BV)</title>
        <anchor id="ch0035s0026s0002a0001"/>
        <anchor id="ch0035s0026s0002a0002"/>
        <para id="ch0035s0026s0002p0001">BV occurs when conditions result in overgrowth of usual vaginal microbiota with various anaerobic organisms, including<emphasis>G. vaginalis, Mobiluncus</emphasis>, and <emphasis>Bacteroides</emphasis> (<link linkend="ch0035s0035s0001li0102">102</link>). Diagnosis is best made using the Gram stain and interpreted with a standardized scoring system, such as the Nugent score (<link linkend="ch0035s0035s0001li0103">103</link>). Routine culture of vaginal specimens for diagnosis of BV is not recommended, as <emphasis>G. vaginalis</emphasis> is a part of the vaginal microbiota. A variety of non-culture-based assays using hybridization or NAAT are commercially available for the simultaneous detection of BV, <emphasis>Candida</emphasis> spp., and <emphasis>T. vaginalis</emphasis> (<link linkend="ch0035s0035s0001li0104">104</link>).</para>
      </sect2>
      <sect2 id="ch0035s0026s0003">
        <title>Haemophilus ducreyi (Also See Chapter 37)</title>
        <anchor id="ch0035s0026s0003a0001"/>
        <anchor id="ch0035s0026s0003a0002"/>
        <para id="ch0035s0026s0003p0001">If infection with<emphasis>H. ducreyi</emphasis> is suspected, material from the base of the ulcer is collected and held at room temperature until it can be processed. One swab is used to prepare a smear for Gram staining. The presence of many small, pleomorphic Gram-negative bacilli and coccobacilli arranged in chains and groups (“school of fish”) suggests <emphasis>H. ducreyi</emphasis>, but this is rarely seen. Recovery of the organisms requires culture using an enriched medium, such as GC agar, but ulcer disease is much better diagnosed with molecular methods.</para>
      </sect2>
      <sect2 id="ch0035s0026s0004">
        <title>Actinomyces spp. (Also See Chapter 55)</title>
        <anchor id="ch0035s0026s0004a0001"/>
        <anchor id="ch0035s0026s0004a0002"/>
        <para id="ch0035s0026s0004p0001"><emphasis>Actinomyces</emphasis> spp., such as <emphasis>Actinomyces israelii</emphasis>, may cause pelvic inflammatory disease in women who use intrauterine contraceptive devices (IUDs). An IUD submitted for culture should be placed in a sterile liquid medium (preferably reduced, such as thioglycolate) and vortexed, and the liquid medium should be used to inoculate aerobic and anaerobic culture media. Inflammatory debris and tissue attached to the IUD should be removed and cultured aerobically and anaerobically. Anaerobic cultures should be incubated for 10 to 14 days to recover <emphasis>Actinomyces</emphasis> spp. <emphasis>Actinomyces</emphasis> spp. produce small knots of intertwined bacterial filaments called grains or granules, which may be 1 mm or more in diameter. These grains should be crushed on a slide for Gram staining and transferred to medium for culture. The presence of branching Gram-positive filaments suggests <emphasis>Actinomyces</emphasis> spp. in this clinical setting, and culture confirms the diagnosis.</para>
      </sect2>
      <sect2 id="ch0035s0026s0005">
        <title>Screening for Group B Streptococcus</title>
        <anchor id="ch0035s0026s0005a0001"/>
        <anchor id="ch0035s0026s0005a0002"/>
        <para id="ch0035s0026s0005p0001">Pregnant women colonized vaginally or rectally with group B streptococci prior to delivery are at increased risk of infecting their newborns during delivery. Current recommendations are to collect vaginal and rectal swabs in transport medium (Amies or Stuart’s) at 36 0/7 to 37 6/7 weeks of gestation for culture in a single enrichment broth, such as LIM broth (<link linkend="ch0035s0035s0001li0105">105</link>, <link linkend="ch0035s0035s0001li0106">106</link>). NAATs for group B <emphasis>Streptococcus</emphasis> with comparable or improved sensitivity are commercially available but still require at least 18 h of incubation in enrichment broth before testing for optimal sensitivity (<link linkend="ch0035s0035s0001li0107">107</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0035s0027">
      <title>Lower Respiratory Tract</title>
      <anchor id="ch0035s0027a0001"/>
      <anchor id="ch0035s0027a0002"/>
      <para id="ch0035s0027p0001">Specimens from the lower respiratory tract are submitted to determine the etiology of airway disease, including tracheobronchitis, pneumonia, lung abscess, and empyema (<link linkend="ch0035s0035s0001li0108">108</link>). Usual specimens submitted consist of sputum (expectorated and induced); endotracheal tube aspirates; bronchial brushings, washes, or alveolar lavages (collected blindly or during bronchoscopy); and pleural fluid. Specimens should be transported to the laboratory promptly and processed without delay to preserve viability of fastidious organisms such as <emphasis>S. pneumoniae</emphasis>. If delays are unavoidable, specimens should be refrigerated.</para>
      <para id="ch0035s0027p0002">Lower respiratory tract secretions produced in the context of infection usually contain acute inflammatory cells such as PMNs. To prevent bacterial workup and reporting of the oropharyngeal microbiota rather than microbes from lower airway secretions, sputum specimens should be assessed for SECs (<link linkend="ch0035s0035s0001li0109">109</link>, <link linkend="ch0035s0035s0001li0110">110</link>). Increased numbers of SECs (generally defined as ≥25 per 10× objective microscopic field) indicate gross contamination with oropharyngeal contents, and these specimens are rejected. Other screening methods take into account the relative amounts of PMNs and SECs, and specimens are accepted or rejected based on the ratio of inflammation to contamination. These screening methods should be used cautiously for immunocompromised patients (<link linkend="ch0035s0035s0001li0111">111</link>). Respiratory tract specimens for the detection of <emphasis>M. tuberculosis</emphasis> should not be screened for adequacy, as all specimens representing the lower respiratory tract are considered acceptable for the detection of this microorganism (<link linkend="ch0035s0035s0001li0112">112</link>). Cultures of respiratory tract material should include a selective Gram-negative medium, such as MacConkey agar, sheep blood agar, or colistin-nalidixic acid agar, and chocolate agar for the detection of <emphasis>Haemophilus</emphasis> spp. Culture plates should be incubated at 35°C in 3 to 5% CO<subscript>2</subscript> for 48 h. Diagnosis of legionellosis can be accomplished by culture, urine antigen detection, or NAAT. A multiplex PCR panel for the detection of 26 respiratory pathogens, including <emphasis>Legionella pneumophilia</emphasis>, using sputum, endotracheal aspirates, or bronchial alveolar lavage (BAL) specimens is commercially available (FilmArray Pneumonia panel; BioFire Diagnostics, Salt Lake City, UT) (<link linkend="ch0035s0035s0001li0113">113</link>).</para>
      <sect2 id="ch0035s0027s0001">
        <title>Special Considerations for Lower Respiratory Tract Specimens</title>
        <anchor id="ch0035s0027s0001a0001"/>
        <anchor id="ch0035s0027s0001a0002"/>
        <sect3 id="ch0035s0027s0001s0001">
          <title>Specimens Collected during Bronchoscopy</title>
          <anchor id="ch0035s0027s0001s0001a0001"/>
          <anchor id="ch0035s0027s0001s0001a0002"/>
          <para id="ch0035s0027s0001s0001p0001">Bronchoalveolar lavage fluid and protected specimen brush (PSB) specimens from patients with suspected pneumonia should be cultured quantitatively to evaluate the significance of potential pathogens recovered (<link linkend="ch0035s0035s0001li0114">114</link>). To collect bronchial brush specimens, the brush should be placed in 1 ml of sterile nonbacteriostatic saline or lactated Ringer’s solution, which is less inhibitory to <emphasis>Legionella</emphasis> species. All specimens should be processed rapidly upon receipt in the microbiology laboratory. In the laboratory, the bronchoalveolar lavage fluid and PSB specimens are agitated on a vortex mixer, a smear is prepared by cytocentrifugation for Gram staining, and 0.01 ml of specimen is inoculated to appropriate media by using a pipette or calibrated loop. If anaerobes are to be cultured (from PSB specimens only), chopped meat or anaerobic thioglycolate medium can be used. Both PMNs and SECs should be quantitated via the Gram stain to report on the quality of the specimen received for culture, but the results should not be used as rejection criteria.</para>
          <anchor id="ch0035s0027s0001s0001a0003"/>
          <beginpage pagenum="380"/>
        </sect3>
        <sect3 id="ch0035s0027s0001s0002">
          <title>Specimens from Patients with Cystic Fibrosis (Also See Chapter 46)</title>
          <anchor id="ch0035s0027s0001s0002a0001"/>
          <anchor id="ch0035s0027s0001s0002a0002"/>
          <para id="ch0035s0027s0001s0002p0001">Respiratory samples from cystic fibrosis patients require additional media to detect the important pathogens unique to these patients (<link linkend="ch0035s0035s0001li0115">115</link>). Specimens submitted for culture include sputum, aspirates, or deep throat swabs. Additional selective media include <emphasis>Burkholderia cepacia</emphasis> selective agar or oxidative-fermentative polymyxin B-bacitracin-lactose agar for recovery of <emphasis>Burkholderia cepacia</emphasis> complex, mannitol salt agar or <emphasis>S. aureus</emphasis> chromogenic agar for enhanced recovery of <emphasis>S. aureus</emphasis>, and inhibitory mold agar for enhanced recovery of filamentous fungi (<link linkend="ch0035s0035s0001li0116">116</link>, <link linkend="ch0035s0035s0001li0117">117</link>). <emphasis>B. cepacia</emphasis> selective agar can also be used for the recovery of rapidly growing mycobacteria from these patients (<link linkend="ch0035s0035s0001li0118">118</link>).</para>
        </sect3>
      </sect2>
    </sect1>
    <sect1 id="ch0035s0028">
      <title>Upper Respiratory Tract</title>
      <anchor id="ch0035s0028a0001"/>
      <anchor id="ch0035s0028a0002"/>
      <para id="ch0035s0028p0001">Upper respiratory tract specimens include the external nares (for MRSA detection), nasopharynx, throat, oral ulcerations, and inflammatory material from the nasal sinuses. Although few serious diseases involve these areas, many pathogens colonize or persist in these sites while causing symptomatic infection in deeper, less accessible sites (<link linkend="ch0035s0035s0001li0119">119</link>). Detection of group A <emphasis>Streptococcus</emphasis> (GAS) to diagnose pharyngitis is the most common test ordered for specimens from the upper respiratory tract. Throat swabs for detection of GAS only can be sent dry, without transport medium. Optimal media to recover GAS are horse and sheep blood agar and selective streptococcal agar, which makes the organism easier to visualize by inhibiting accompanying members of the oral microbiota but may delay the appearance of colonies of <emphasis>S. pyogenes</emphasis>. Due to the insensitivity of GAS rapid antigen testing and the risk of poststreptococcal sequelae, pediatric patients with a negative GAS antigen test should also have a culture performed (<link linkend="ch0035s0035s0001li0120">120</link>). Two throat swabs should be collected to allow culture if necessary. If only one swab is received, the culture should be inoculated first. Adult patients do not require culture backup following negative rapid antigen testing (<link linkend="ch0035s0035s0001li0120">120</link>). Rapid NAAT tests for GAS pharyngitis that can be performed at the point of care with results in approximately 15 min are available (<link linkend="ch0035s0035s0001li0121">121</link>). These rapid molecular tests have shown sensitivities equivalent to that of reference culture, ≥97%, and eliminate the need for backup testing in the event of negative results.</para>
      <para id="ch0035s0028p0002">Group C and G streptococci,<emphasis>Fusobacterium necrophorum, Arcanobacterium haemolyticum, N. gonorrhoeae, Corynebacterium diphtheriae</emphasis>, mycoplasmas, and chlamydiae may also occasionally cause pharyngitis. Anaerobic culture from throat swabs is necessary for the recovery of <emphasis>F. necrophorum</emphasis>. A standard swab is sufficient and should be placed in a transport carrier containing Amies or modified Stuart’s medium (<link linkend="ch0035s0035s0001li0122">122</link>). NAATs are the test of choice for detection of <emphasis>N. gonorrhoeae</emphasis> in the throat, due to their enhanced sensitivity.</para>
      <para id="ch0035s0028p0003">Nasopharyngeal specimens are generally submitted only for detection of the causative agents of pertussis or whooping cough. NAAT is the most sensitive method for detecting<emphasis>B. pertussis</emphasis> and <emphasis>Bordetella parapertussis</emphasis>, and a number of FDA-approved assays are commercially available (<link linkend="ch0035s0035s0001li0123">123</link>). For recovery of <emphasis>Bordetella</emphasis> spp., a small-tipped Dacron or rayon swab is optimal, as cotton-tipped or calcium-alginate swabs may be toxic to the organism. The sensitivity of culture decreases dramatically after the first 2 weeks of illness, and it is recommended primarily when there is a suspicion of a pertussis outbreak (<link linkend="ch0035s0035s0001li0124">124</link>).</para>
      <para id="ch0035s0028p0004">Inflammatory material from the nasal sinuses should be cultured to detect the etiologies of sinusitis. Nearly all cases of bacterial sinusitis follow a primary upper respiratory tract viral infection. Bacteria are trapped in the sinus as a result of damage to the epithelial lining cells of the sinus, and inflammation and swelling narrow or close the nasal ostium, preventing normal drainage (<link linkend="ch0035s0035s0001li0125">125</link>). Specimens collected during endoscopic procedures by physicians specializing in otorhinolaryngology are optimal, since they are taken directly from the infected sinus, avoiding contamination by normal members of the microbiota in the nasal passages. Aspirates, washes, scrapings or debridement material, and biopsy material should be kept moist and sent in a sterile container to the laboratory. Aerobic culture is needed in all cases; anaerobic transport and culture may be needed in cases of chronic sinusitis. Although swabs obtained with endoscopic guidance correlate well with aspirates for recovery of bacteria, they do a poor job of recovering fungi, which have been implicated as etiological agents of chronic sinusitis (<link linkend="ch0035s0035s0001li0126">126</link>).</para>
    </sect1>
    <sect1 id="ch0035s0029">
      <title>Tissue Biopsy Samples</title>
      <anchor id="ch0035s0029a0001"/>
      <anchor id="ch0035s0029a0002"/>
      <para id="ch0035s0029p0001">Tissue from a sterile site is usually obtained during a surgical procedure and should be of a sufficient volume for all possible tests, including histopathology and various microbiological studies. A 1-cm<superscript>3</superscript> piece or 1 g of tissue should suffice for any microbiology requests. This is difficult with fine-needle aspirates and biopsy samples, which usually are minuscule. Tissue should be transported in a sterile container as rapidly as possible to prevent drying. To maintain moisture, very small pieces of tissue can be placed on a square of sterile gauze saturated with sterile, nonbacteriostatic saline. If anaerobic cultures are requested, the tissue should be transported in an anaerobic transport tube or vial, many of which maintain anaerobes extremely well even during overnight shipping. Larger pieces of tissue (&gt;1 cm<superscript>3</superscript>) maintain a reduced atmosphere in spite of brief aerobic transport. Oxygen-free transport may not be necessary in this circumstance, and the absence of anaerobic transport should not disqualify large pieces of tissue from anaerobic culture. Once the tissue is received in the laboratory, any frankly infected portions of tissue should be selected prior to grinding (or mincing for fungal cultures); Gram staining and culture should be performed.</para>
      <para id="ch0035s0029p0002">Some agents of bacterial infections in tissue cannot be cultivated<emphasis>in vitro</emphasis> using standard microbiological media. These infections include syphilis, caused by <emphasis>Treponema pallidum</emphasis>, donovanosis, caused by <emphasis>Klebsiella</emphasis> (<emphasis>Calymmatobacterium</emphasis>) <emphasis>granulomatis</emphasis>, rat bite fever, caused by <emphasis>Spirillum minus</emphasis>, and others. The organisms may be visualized by histopathologic stains. Newer molecular technologies are proving to be most reliable, especially for organisms causing genital ulcer disease and those found in biofilms (<link linkend="ch0035s0035s0001li0127">127</link>, <link linkend="ch0035s0035s0001li0128">128</link>). The use of DNA sequencing to identify bacteria seen in tissue sections by histology, including <emphasis>Tropheryma whipplei, Coxiella burnetii</emphasis>, and <emphasis>Bartonella henselae</emphasis>, is gaining favor (<link linkend="ch0035s0035s0001li0041">41</link>).</para>
      <para id="ch0035s0029p0003">Tissue from traumatic wound or burn injury may be submitted for quantitative culture, with results of ≥10<superscript>5</superscript> CFU/g being used to predict the likelihood of the development of wound-related sepsis (<link linkend="ch0035s0035s0001li0129">129</link>). Full-thickness punch biopsy samples should be collected for this process, and a detailed procedure can be found in the <emphasis>Clinical Microbiology Procedures Handbook</emphasis> (<link linkend="ch0035s0035s0001li0003">3</link>). Limitations include the lack of reproducible results and the low predictive value compared to histologic examination of tissue (<link linkend="ch0035s0035s0001li0130">130</link>).</para>
      <anchor id="ch0035s0029a0003"/>
      <beginpage pagenum="381"/>
    </sect1>
    <sect1 id="ch0035s0030">
      <title>Bone Marrow Transport and Culture</title>
      <anchor id="ch0035s0030a0001"/>
      <anchor id="ch0035s0030a0002"/>
      <para id="ch0035s0030p0001">Although bone marrow aspirate cultures may be helpful in identifying disseminated fungal and mycobacterial diseases, they are unlikely to assist in the identification of most bacterial diseases (<link linkend="ch0035s0035s0001li0131">131</link>, <link linkend="ch0035s0035s0001li0132">132</link>). It is also a routine procedure in some transplant centers to submit harvested bone marrow aspirates in either lysis centrifugation (Isolator) tubes or sterile containers for bacterial culture. Bone marrow aspirates received in a sterile container should be transferred to a blood culture bottle and incubated in the automated blood culture instrument. If bone marrow culture is performed, direct Gram staining of bone marrow aspirates is not helpful and should not be a routine component of bacterial culture.</para>
    </sect1>
    <sect1 id="ch0035s0031">
      <title>Lymph Nodes</title>
      <anchor id="ch0035s0031a0001"/>
      <anchor id="ch0035s0031a0002"/>
      <para id="ch0035s0031p0001">Aspirates and biopsy samples from lymph nodes are usually sent to the laboratory for detection of nonbacterial infectious agents. However, studies of lymph nodes from patients with mycobacterial disease, cat scratch disease, plague, brucellosis, or tularemia can be fruitful. Initial handling of the tissue itself and of the culture plates, whether showing growth or not, should be done with extreme care, and all biosafety practices should be employed. Plates should be taped to prevent accidental opening.</para>
    </sect1>
    <sect1 id="ch0035s0032">
      <title>Necrotizing Fasciitis</title>
      <anchor id="ch0035s0032a0001"/>
      <anchor id="ch0035s0032a0002"/>
      <para id="ch0035s0032p0001">Necrotizing fasciitis and gas gangrene (myonecrosis) are medical emergencies requiring immediate diagnosis and therapy that may include antimicrobials and surgical debridement (<link linkend="ch0035s0035s0001li0133">133</link>). Necrotizing fasciitis and gas gangrene are most commonly caused by toxin-producing <emphasis>Streptococcus pyogenes</emphasis>, other beta-hemolytic streptococci, <emphasis>S. aureus, Clostridium</emphasis> spp., and mixed aerobic and anaerobic bacteria (<link linkend="ch0035s0035s0001li0133">133</link>, <link linkend="ch0035s0035s0001li0134">134</link>). Gram-stained smears of intraoperative tissue, fascia, muscle, and/or fluid are particularly helpful and show necrotic cell debris, rare or few PMNs (because of cell lysis), and the causative bacteria, which should be confirmed by culture.</para>
    </sect1>
    <sect1 id="ch0035s0033">
      <title>Cellulitis</title>
      <anchor id="ch0035s0033a0001"/>
      <anchor id="ch0035s0033a0002"/>
      <para id="ch0035s0033p0001">Several studies have shown that aspirates from the leading edge of areas of cellulitis are not clinically useful. Injection of nonbacteriostatic saline and subsequent aspiration may be necessary to obtain enough material to culture (<link linkend="ch0035s0035s0001li0135">135</link>). Under the best of conditions, these specimens are unlikely to be positive and so they are not recommended. Blood cultures from patients with cellulitis also are unlikely to be positive (<link linkend="ch0035s0035s0001li0134">134</link>). Tissue biopsy may be required if microbiological testing is deemed crucial for a rapidly progressing lesion.</para>
    </sect1>
    <sect1 id="ch0035s0034">
      <title>Urinary Tract</title>
      <anchor id="ch0035s0034a0001"/>
      <anchor id="ch0035s0034a0002"/>
      <para id="ch0035s0034p0001">Diseases of the urinary tract include prostatitis, urethral syndrome, cystitis, and pyelonephritis. Urine, prostatic secretions, or urethral specimens are needed to diagnose these diseases. Urine culture is the most common test performed by most microbiology laboratories. However, contamination of urine, defined as growth of commensal skin, vaginal, or fecal microbiota in the absence of true urinary tract infection (UTI), is detected in approximately 5 to 40% of cultures. There is ongoing controversy regarding how urine should be collected to minimize contamination, but traditional skin cleansing prior to collection of midstream urine is still recommended, and provision of written instructions on proper collection can help reduce contamination rates (<link linkend="ch0035s0035s0001li0136">136</link>). Improper urine specimen collection, storage, and transport to the laboratory will result in inaccurate and misleading culture results. Therefore, urine specimens should be processed within 30 min of collection, refrigerated for no more than 24 h if delay is expected, or placed in transport tubes containing boric acid at room temperature for 24 h (<link linkend="ch0035s0035s0001li0004">4</link>).</para>
      <para id="ch0035s0034p0002">Chronic indwelling urinary catheters, percutaneous nephrostomy tubes, and ileal conduits are increasingly encountered in patients and present unique challenges in collection of specimens while avoiding colonizing flora. Culture from indwelling catheters is discouraged, but if it is necessary, the specimen should be taken from the sampling port of a newly inserted catheter (<link linkend="ch0035s0035s0001li0004">4</link>). Similarly, collection of specimens from ileal conduits and nephrostomy tubes is discouraged, as they are chronically colonized with bacteria (<link linkend="ch0035s0035s0001li0004">4</link>).</para>
      <para id="ch0035s0034p0003">The standard for quantitative bacterial culture of urine is the inoculation of 0.01 or 0.001 ml of specimen using a calibrated pipette or a plastic or wire loop to appropriate media, usually sheep blood and MacConkey agars. If a loop is used, it should be dipped vertically into the well-mixed urine, just far enough to cover the loop. Prior to plate inoculation, it is necessary to ensure that a film of urine fills the loop with no bubbles to alter the calibrated volume. The specimen should be spread over the surface of the agar plate by streaking from top to bottom in a vertical line and again from top to bottom perpendicular to this line in a back-and-forth fashion.</para>
    </sect1>
    <sect1 id="ch0035s0035">
      <title>Wounds</title>
      <anchor id="ch0035s0035a0001"/>
      <anchor id="ch0035s0035a0002"/>
      <para id="ch0035s0035p0001">Superficial wound specimens are frequently submitted on swabs and often grow multiple organisms, including members of the commensal microbiota, which makes interpretation and treatment confusing for physicians. While superficial swabs are easy to collect, they should be discouraged. If a swab must be used, a flocked swab and transport medium system should be requested (<link linkend="ch0035s0035s0001li0022">22</link>–<link linkend="ch0035s0035s0001li0025">25</link>). A meta-analysis examining the usefulness of lower-extremity swabs compared to deeper cultures found the sensitivity of swabs to be only 49% and the specificity to be 62%, with a positive likelihood ratio of 1.1 and a negative likelihood ratio of 0.67 (<link linkend="ch0035s0035s0001li0137">137</link>). In general, tissue specimens obtained by biopsy, ulcer curettage, or aspiration are preferred (<link linkend="ch0035s0035s0001li0138">138</link>). If a transport system is not used, the specimens should be transferred to a sterile container and transported to the laboratory within 2 h at room temperature to prevent loss of fastidious organisms and prevent overgrowth of contaminating species.</para>
      <para id="ch0035s0035p0002">It is helpful to perform a Gram stain on all wound specimens to interpret the culture. The presence of a predominant bacterial morphotype(s), acute inflammatory cells (PMNs), intracellular bacteria, and cell necrosis suggest a good-quality specimen (<link linkend="ch0035s0035s0001li0139">139</link>). Excessive numbers of SECs suggest contamination with members of the cutaneous microbiota. It is acceptable to limit workup of bacterial isolates when the specimen shows contamination.</para>
      <sect2 id="ch0035s0035s0001">
        <title>REFERENCES</title>
        <anchor id="ch0035s0035s0001a0001"/>
        <anchor id="ch0035s0035s0001a0002"/>
        <anchor id="ch0035s0035s0001a0003"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0035s0035s0001li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Miller JM.</emphasis> 2016. Poorly collected specimens may have a negative impact on your antibiotic stewardship program. <emphasis><citetitle>Clin Microbiol Newsl</citetitle></emphasis> <emphasis role="strong">38:</emphasis>43–48.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">van Walraven C, Naylor CD.</emphasis> 1998. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. <emphasis><citetitle>JAMA</citetitle></emphasis> <emphasis role="strong">280:</emphasis>550–558.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">Leber A (ed).</emphasis> 2022. <emphasis><citetitle>Clinical Microbiology Procedures Handbook</citetitle></emphasis>, 5th ed. ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S III, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD.</emphasis> 2018. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">67:</emphasis>e1–e94.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Thomson JR.</emphasis> 2002. Use of microbiology laboratory tests in the diagnosis of infectious diseases, p 1–41. <emphasis><citetitle>In</citetitle></emphasis> Tan JS (ed), <emphasis><citetitle>Expert Guide to Infectious Diseases</citetitle></emphasis>. American College of Physicians, Philadelphia, PA.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Hughes JG, Vetter EA, Patel R, Schleck CD, Harmsen S, Turgeant LT, Cockerill FR III.</emphasis> 2001. Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">39:</emphasis>4468–4471.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Tande AJ, Patel R.</emphasis> 2014. Prosthetic joint infection. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">27:</emphasis>302–345.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR, Infectious Diseases Society of America.</emphasis> 2013. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">56:</emphasis>e1–e25.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R.</emphasis> 2007. Sonication of removed hip and knee prostheses for diagnosis of infection. <emphasis><citetitle>N Engl J Med</citetitle></emphasis> <emphasis role="strong">357:</emphasis>654–663.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Mason PK, Dimarco JP, Ferguson JD, Mahapatra S, Mangrum JM, Bilchick KC, Moorman JR, Lake DE, Bergin JD.</emphasis> 2011. Sonication of explanted cardiac rhythm management devices for the diagnosis of pocket infections and asymptomatic bacterial colonization. <emphasis><citetitle>Pacing Clin Electrophysiol</citetitle></emphasis> <emphasis role="strong">34:</emphasis>143–149.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Sampedro MF, Huddleston PM, Piper KE, Karau MJ, Dekutoski MB, Yaszemski MJ, Currier BL, Mandrekar JN, Osmon DR, McDowell A, Patrick S, Steckelberg JM, Patel R.</emphasis> 2010. A biofilm approach to detect bacteria on removed spinal implants. <emphasis><citetitle>Spine</citetitle></emphasis> <emphasis role="strong">35:</emphasis>1218–1224.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Dy Chua J, Abdul-Karim A, Mawhorter S, Procop GW, Tchou P, Niebauer M, Saliba W, Schweikert R, Wilkoff BL.</emphasis> 2005. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. <emphasis><citetitle>Pacing Clin Electrophysiol</citetitle></emphasis> <emphasis role="strong">28:</emphasis>1276–1281.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Nair B, Stapp J, Stapp L, Bugni L, Van Dalfsen J, Burns JL.</emphasis> 2002. Utility of Gram staining for evaluation of the quality of cystic fibrosis sputum samples. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">40:</emphasis>2791–2794.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Schifman RB, Meier F.</emphasis> 1991. <emphasis><citetitle>Q-Probes: Sputum Specimen Adequacy: Data Analysis and Critique</citetitle></emphasis>. College of American Pathologists, Chicago, IL.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">Engel MF, van Manen L, Hoepelman AI, Thijsen S, Oosterheert JJ.</emphasis> 2013. Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for <emphasis><citetitle>Legionella</citetitle></emphasis> spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation. <emphasis><citetitle>J Clin Pathol</citetitle></emphasis> <emphasis role="strong">66:</emphasis>797–802.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Jean S, Yarbrough ML, Anderson NW, Burnham CA.</emphasis> 2019. Culture of rectal swab specimens for enteric bacterial pathogens decreases time to test result while preserving assay sensitivity compared to bulk fecal specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">57:</emphasis>e02077-18.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Kellner T, Parsons B, Chui L, Berenger BM, Xie J, Burnham CA, Tarr PI, Lee BE, Nettel-Aguirre A, Szelewicki J, Vanderkooi OG, Pang XL, Zelyas N, Freedman SB.</emphasis> 2019. Comparative evaluation of enteric bacterial culture and a molecular multiplex syndromic panel in children with acute gastroenteritis. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">57:</emphasis>e00205-19.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">Rohner P, Pittet D, Pepey B, Nije-Kinge T, Auckenthaler R.</emphasis> 1997. Etiological agents of infectious diarrhea: implications for requests for microbial culture. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">35:</emphasis>1427–1432.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Church DL, Cadrain G, Kabani A, Jadavji T, Trevenen C.</emphasis> 1995. Practice guidelines for ordering stool cultures in a pediatric population. Alberta Children’s Hospital, Calgary, Alberta, <emphasis><citetitle>Canada. Am J Clin Pathol</citetitle></emphasis> <emphasis role="strong">103:</emphasis>149–153.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Furuya-Kanamori L, Marquess J, Yakob L, Riley TV, Paterson DL, Foster NF, Huber CA, Clements ACA.</emphasis> 2015. Asymptomatic <emphasis><citetitle>Clostridium difficile</citetitle></emphasis> colonization: epidemiology and clinical implications. <emphasis><citetitle>BMC Infect Dis</citetitle></emphasis> <emphasis role="strong">15:</emphasis>516.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Demetriou M, Papanas N, Panopoulou M, Papatheodorou K, Bounovas A, Maltezos E.</emphasis> 2013. Tissue and swab culture in diabetic foot infections: neuropathic versus neuroischemic ulcers. <emphasis><citetitle>Int J Low Extrem Wounds</citetitle></emphasis> <emphasis role="strong">12:</emphasis>87–93.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Nys S, Vijgen S, Magerman K, Cartuyvels R.</emphasis> 2010. Comparison of Copan eSwab with the Copan Venturi Transystem for the quantitative survival of <emphasis><citetitle>Escherichia coli</citetitle>, <citetitle>Streptococcus agalactiae</citetitle></emphasis> and <emphasis><citetitle>Candida albicans</citetitle></emphasis>. <emphasis><citetitle>Eur J Clin Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">29:</emphasis>453–456.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Tyrrell KL, Citron DM, Leoncio ES, Goldstein EJC.</emphasis> 2016. Comparison of the Copan eSwab system with an agar swab transport system for maintenance of fastidious anaerobic bacterium viability. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>1364–1367.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Jones G, Matthews R, Cunningham R, Jenks P.</emphasis> 2011. Comparison of automated processing of flocked swabs with manual processing of fiber swabs for detection of nasal carriage of <emphasis><citetitle>Staphylococcus aureus</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>2717–2718.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Saegeman V, Flamaing J, Muller J, Peetermans WE, Stuyck J, Verhaegen J.</emphasis> 2011. Clinical evaluation of the Copan ESwab for methicillin-resistant Staphylococcus aureus detection and culture of wounds. <emphasis><citetitle>Eur J Clin Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">30:</emphasis>943–949.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Aslangul E, M’bemba J, Caillat-Vigneron N, Coignard S, Larger E, Boitard C, Lipsky BA.</emphasis> 2013. Diagnosing diabetic foot osteomyelitis in patients without signs of soft tissue infection by coupling hybrid 67Ga SPECT/CT with bedside percutaneous bone puncture. <emphasis><citetitle>Diabetes Care</citetitle></emphasis> <emphasis role="strong">36:</emphasis>2203–2210.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">LaRocco MT, Franek J, Leibach EK, Weissfeld AS, Kraft CS, Sautter RL, Baselski V, Rodahl D, Peterson EJ, Cornish NE.</emphasis> 2016. Effectiveness of preanalytic practices on contamination and diagnostic accuracy of urine cultures: a laboratory medicine best practices systematic review and meta-analysis. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">29:</emphasis>105–147.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Canadian Paediatric Society,</emphasis> Infectious Diseases and Immunization Committee<emphasis role="strong">.</emphasis> 2004. Bag urine specimens still not appropriate in diagnosing urinary tract infections in infants. <emphasis><citetitle>Can J Infect Dis Med Microbiol</citetitle></emphasis> <emphasis role="strong">15:</emphasis>210–211.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Harrington SM.</emphasis> 2014. If specimen collection and processing guidelines fall, does anyone hear them? Pre-analytical conundrums in clinical microbiology. <emphasis><citetitle>Clin Microbiol Newsl</citetitle></emphasis> <emphasis role="strong">36:</emphasis>105–114.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Clinical and Laboratory Standards Institute.</emphasis> 2014. <emphasis><citetitle>Quality Control of Microbiological Transport Systems: Approved Standard. CLSI Document M40-A</citetitle></emphasis>. Clinical and Laboratory Standards Institute, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Rishmawi N, Ghneim R, Kattan R, Ghneim R, Zoughbi M, Abu-Diab A, Turkuman S, Dauodi R, Shomali I, Issa A-R, Siriani I, Marzouka H, Schmid I, Hindiyeh MY.</emphasis> 2007. Survival of fastidious and nonfastidious aerobic bacteria in three bacterial transport swab systems. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">45:</emphasis>1278–1283.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Drake C, Barenfanger J, Lawhorn J, Verhulst S.</emphasis> 2005. Comparison of Easy-Flow Copan Liquid Stuart’s and Starplex Swab transport systems for recovery of fastidious aerobic bacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">43:</emphasis>1301–1303.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0033" role="bibliographyEntry">
            <anchor id="ch0035s0035s0001a0004"/>
            <para>33.<emphasis role="strong">Doern GV.</emphasis> 2000. Detection of selected fastidious bacteria. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">30:</emphasis>166–173.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Miller JM, Miller SA.</emphasis> 2017. <emphasis><citetitle>A Guide to Specimen Management in Clinical Microbiology</citetitle></emphasis>, 3rd ed. ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Shanholtzer CJ, Schaper PJ, Peterson LR.</emphasis> 1982. Concentrated gram stain smears prepared with a cytospin centrifuge. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">16:</emphasis>1052–1056.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">D’Souza HA, Campbell M, Baron EJ.</emphasis> 2004. Practical bench comparison of BBL CHROMagar Orientation and standard two-plate media for urine cultures. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>60–64.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">van Dijk S, Bruins MJ, Ruijs GJ.</emphasis> 2009. Evaluation and implementation of a chromogenic agar medium for <emphasis><citetitle>Salmonella</citetitle></emphasis> detection in stool in routine laboratory diagnostics. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>456–458.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Lee S, Park YJ, Park KG, Jekarl DW, Chae H, Yoo JK, Seo SW, Choi JE, Lim JH, Heo SM, Seo JH.</emphasis> 2013. Comparative evaluation of three chromogenic media combined with broth enrichment and the real-time PCR-based Xpert MRSA assay for screening of methicillin-resistant <emphasis><citetitle>Staphylococcus aureus</citetitle></emphasis> in nasal swabs. <emphasis><citetitle>Ann Lab Med</citetitle></emphasis> <emphasis role="strong">33:</emphasis>255–260.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Perry JD, Naqvi SH, Mirza IA, Alizai SA, Hussain A, Ghirardi S, Orenga S, Wilkinson K, Woodford N, Zhang J, Livermore DM, Abbasi SA, Raza MW.</emphasis> 2011. Prevalence of faecal carriage of <emphasis><citetitle>Enterobacteriaceae</citetitle></emphasis> with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. <emphasis><citetitle>J Antimicrob Chemother</citetitle></emphasis> <emphasis role="strong">66:</emphasis>2288–2294.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Ledeboer NA, Dallas SD.</emphasis> 2014. The automated clinical microbiology laboratory: fact or fantasy? <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>3140–3146.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Buchan BW, Ledeboer NA.</emphasis> 2014. Emerging technologies for the clinical microbiology laboratory. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">27:</emphasis>783–822.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Morris AJ, Wilson SJ, Marx CE, Wilson ML, Mirrett S, Reller LB.</emphasis> 1995. Clinical impact of bacteria and fungi recovered only from broth cultures. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">33:</emphasis>161–165.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Sampedro MF, Piper KE, McDowell A, Patrick S, Mandrekar JN, Rouse MS, Steckelberg JM, Patel R.</emphasis> 2009. Species of <emphasis><citetitle>Propionibacterium</citetitle></emphasis> and <emphasis><citetitle>Propionibacterium acnes</citetitle></emphasis> phylotypes associated with orthopedic implants. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">64:</emphasis>138–145.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">Singh K.</emphasis> 2009. Laboratory-acquired infections. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">49:</emphasis>142–147.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Riedel S.</emphasis> 2014. The value of postmortem microbiology cultures. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>1028–1033.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, et al.</emphasis> 2021. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. <emphasis><citetitle>Crit Care Med</citetitle></emphasis> <emphasis role="strong">49:</emphasis>e1063–e1143.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Weiss SL, Peters MJ, Alhazzani W, Agus MS, Flori HR, et al.</emphasis> 2020. Surviving Sepsis Campaign international Guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. <emphasis><citetitle>Pediatr Crit Care Med</citetitle></emphasis> <emphasis role="strong">21:</emphasis>e52–e106.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Clinical and Laboratory Standards Institute.</emphasis> 2022. <emphasis><citetitle>Principles and Procedures for Blood Cultures</citetitle></emphasis>, 2nd ed. CLSI document M47-A. Clinical and Laboratory Standards Institute, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Doern GV, Carroll KC, Diekema DJ, Garey KW, Rupp ME, Weinstein MP, Sexton DJ.</emphasis> 2019. Practical guidance for clinical microbiology laboratories: a comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">33:</emphasis>e00009-19.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Trautner BW, Clarridge JE, Darouiche RO.</emphasis> 2002. Skin antisepsis kits containing alcohol and chlorhexidine gluconate or tincture of iodine are associated with low rates of blood culture contamination. <emphasis><citetitle>Infect Control Hosp Epidemiol</citetitle></emphasis> <emphasis role="strong">23:</emphasis>397–401.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">Story-Roller E, Weinstein MP.</emphasis> 2016. Chlorhexidine versus tincture of iodine for reduction of blood culture contamination rates: a prospective randomized crossover study. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>3007–3009.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Dien Bard J, McElvania TeKippe E.</emphasis> 2016. Diagnosis of bloodstream infections in children. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>1418–1424.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Cockerill FR III, Wilson JW, Vetter EA, Goodman KM, Torgerson CA, Harmsen WS, Schleck CD, Ilstrup DM, Washington JA II, Wilson WR.</emphasis> 2004. Optimal testing parameters for blood cultures. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">38:</emphasis>1724–1730.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Riedel S, Bourbeau P, Swartz B, Brecher S, Carroll KC, Stamper PD, Dunne WM, McCardle T, Walk N, Fiebelkorn K, Sewell D, Richter SS, Beekmann S, Doern GV.</emphasis> 2008. Timing of specimen collection for blood cultures from febrile patients with bacteremia. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">46:</emphasis>1381–1385.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Baron EJ, Scott JD, Tompkins LS.</emphasis> 2005. Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">41:</emphasis>1677–1680.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Petti CA, Bhally HS, Weinstein MP, Joho K, Wakefield T, Reller LB, Carroll KC.</emphasis> 2006. Utility of extended blood culture incubation for isolation of <emphasis><citetitle>Haemophilus</citetitle>, <citetitle>Actinobacillus</citetitle>, <citetitle>Cardiobacterium</citetitle>, <citetitle>Eikenella</citetitle></emphasis>, and <emphasis><citetitle>Kingella</citetitle></emphasis> organisms: a retrospective multicenter evaluation. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">44:</emphasis>257–259.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Reimer LG, Reller LB.</emphasis> 1985. Effect of sodium polyanetholesulfonate and gelatin on the recovery of <emphasis><citetitle>Gardnerella vaginalis</citetitle></emphasis> from blood culture media. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">21:</emphasis>686–688.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Harrell LJ, Mirrett S, Reller LB.</emphasis> 1994. Subcultures of BACTEC-positive but Gram or acridine orange stain-negative NR 6A and 7A blood culture bottles are unnecessary. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">20:</emphasis>121–125.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Juiz PM, Almela M, Melción C, Campo I, Esteban C, Pitart C, Marco F, Vila J.</emphasis> 2012. A comparative study of two different methods of sample preparation for positive blood cultures for the rapid identification of bacteria using MALDI-TOF MS. <emphasis><citetitle>Eur J Clin Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">31:</emphasis>1353–1358.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Leli C, Cenci E, Cardaccia A, Moretti A, D’Alò F, Pagliochini R, Barcaccia M, Farinelli S, Vento S, Bistoni F, Mencacci A.</emphasis> 2013. Rapid identification of bacterial and fungal pathogens from positive blood cultures by MALDI-TOF MS. <emphasis><citetitle>Int J Med Microbiol</citetitle></emphasis> <emphasis role="strong">303:</emphasis>205–209.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R.</emphasis> 2015. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">61:</emphasis>1071–1080.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Felsenstein S, Bender JM, Sposto R, Gentry M, Takemoto C, Bard JD.</emphasis> 2016. Impact of a rapid blood culture assay for Gram-positive identification and detection of resistance markers in a pediatric hospital. <emphasis><citetitle>Arch Pathol Lab Med</citetitle></emphasis> <emphasis role="strong">140:</emphasis>267–275.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF, Infectious Diseases Society of America.</emphasis> 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant <emphasis><citetitle>Staphylococcus aureus</citetitle></emphasis> infections in adults and children. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">52:</emphasis>e18–e55.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Fabre V, Sharara SL, Salinas AB, Carroll KC, Desai S, Cosgrove SE.</emphasis> 2020. Does this patient need blood cultures? A scoping review of indication s for blood cultures in nonneutropenic inpatients. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">71:</emphasis>1339–1347.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Flynn L, Zimmerman LH, Rose A, Zhao J, Wahby K, Dotson B, Wilson R, Tennenberg S.</emphasis> 2012. Vascular catheter tip cultures for suspected catheter-related blood stream infection in the intensive care unit: a tradition whose time has passed? <emphasis><citetitle>Surg Infect (Larchmt)</citetitle></emphasis> <emphasis role="strong">13:</emphasis>245–249.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK.</emphasis> 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">49:</emphasis>1–45.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Bouza E, Alcalá L, Muñoz P, Martín-Rabadán P, Guembe M, Rodríguez-Créixems M, GEIDI and the COMIC study groups.</emphasis> 2013. Can microbiologists help to assess catheter involvement in candidaemic patients before removal? <emphasis><citetitle>Clin Microbiol Infect</citetitle></emphasis> <emphasis role="strong">19:</emphasis>E129–E135.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0068" role="bibliographyEntry">
            <anchor id="ch0035s0035s0001a0005"/>
            <para>68.<emphasis role="strong">Thomson RB Jr, Bertram H.</emphasis> 2001. Laboratory diagnosis of central nervous system infections. <emphasis><citetitle>Infect Dis Clin North Am</citetitle></emphasis> <emphasis role="strong">15:</emphasis>1047–1071.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Perry JL.</emphasis> 1995. Utility of cytocentrifugation for direct examination of clinical specimens. <emphasis><citetitle>Clin Microbiol Newsl</citetitle></emphasis> <emphasis role="strong">17:</emphasis>29–32.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0070" role="bibliographyEntry">
            <para>70.<emphasis role="strong">Bahr NC, Marais S, Caws M, van Crevel R, Wilkinson RJ, Tyagi JS, Thwaites GE, Boulware DR, Tuberculous Meningitis International Research Consortium.</emphasis> 2016. GeneXpert MTB/Rif to diagnose tuberculous meningitis: perhaps the first test but not the last. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">62:</emphasis>1133–1135.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Takahashi T, Tamura M, Takasu T.</emphasis> 2012. The PCR-based diagnosis of central nervous system tuberculosis: up to date. <emphasis><citetitle>Tuberc Res Treat</citetitle></emphasis> <emphasis role="strong">2012:</emphasis>831292.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV, Byamukama A, Bridge SC, Bangdiwala AS, Meya DB, Denkinger CM, Muzoora C, Boulware DR, Williams DA, Taseera K, Nyehangane D, Ivan M, Orikiriza P, Rhein J, Hullsiek KH, Musubire A, Pastick K, Nabeta P, Mwesigye J, Rajasingham R, ASTRO-CM Trial Team.</emphasis> 2018. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. <emphasis><citetitle>Lancet Infect Dis</citetitle></emphasis> <emphasis role="strong">18:</emphasis>68–75.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Sturgis CD, Peterson LR, Warren JR.</emphasis> 1997. Cerebrospinal fluid broth culture isolates: their significance for antibiotic treatment. <emphasis><citetitle>Am J Clin Pathol</citetitle></emphasis> <emphasis role="strong">108:</emphasis>217–221.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TP, Garton HJL, Zunt JR.</emphasis> 2017. 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">64:</emphasis>e34–e65.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, Lephart P, Salimnia H, Schreckenberger PC, DesJarlais S, Reed SL, Chapin KC, LeBlanc L, Johnson JK, Soliven NL, Carroll KC, Miller JA, Dien Bard J, Mestas J, Bankowski M, Enomoto T, Hemmert AC, Bourzac KM.</emphasis> 2016. Multicenter evaluation of BioFire FilmArray Meningitis/Encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>2251–2261.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Das S, Sharma S, Kar S, Sahu SK, Samal B, Mallick A.</emphasis> 2010. Is inclusion of Sabouraud dextrose agar essential for the laboratory diagnosis of fungal keratitis? <emphasis><citetitle>Indian J Ophthalmol</citetitle></emphasis> <emphasis role="strong">58:</emphasis>281–286.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Dize L, West S, Williams JA, Van Der Pol B, Quinn TC, Gaydos CA.</emphasis> 2013. Comparison of the Abbott m2000 RealTime CT assay and the Cepheid GeneXpert CT/NG assay to the Roche Amplicor CT assay for detection of <emphasis><citetitle>Chlamydia trachomatis</citetitle></emphasis> in ocular samples from Tanzania. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">51:</emphasis>1611–1613.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Eldan M, Leibovitz E, Piglansky L, Raiz S, Press J, Yagupsky P, Leiberman A, Dagan R.</emphasis> 2000. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children. <emphasis><citetitle>Pediatr Infect Dis J</citetitle></emphasis> <emphasis role="strong">19:</emphasis>298–303.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Lee H, Kim J, Nguyen V.</emphasis> 2013. Ear infections: otitis externa and otitis media. <emphasis><citetitle>Prim Care</citetitle></emphasis> <emphasis role="strong">40:</emphasis>671–686.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Hirvonen JJ, Kaukoranta SS.</emphasis> 2014. Comparison of FecalSwab and ESwab devices for storage and transportation of diarrheagenic bacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>2334–2339.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Shea S, Kubota KA, Maguire H, Gladbach S, Woron A, Atkinson-Dunn R, Couturier MR, Miller MB, Shea S, Kubota KA, Maguire H, Gladbach S, Woron A, Couturier MR, Miller MB, Gilligan PH.</emphasis> 2016. Clinical Microbiology laboratories’ adoption of culture-independent diagnostic tests is a threat to foodborne-disease surveillance in the United States. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">55:</emphasis>10–19.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Humphries RM, Linscott AJ.</emphasis> 2015. Laboratory diagnosis of bacterial gastroenteritis. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">28:</emphasis>3–31.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Rupnik M, Wilcox MH, Gerding DN.</emphasis> 2009. <emphasis><citetitle>Clostridium difficile</citetitle></emphasis> infection: new developments in epidemiology and pathogenesis. <emphasis><citetitle>Nat Rev Microbiol</citetitle></emphasis> <emphasis role="strong">7:</emphasis>526–536.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH.</emphasis> 2018. Clinical practice guidelines for <emphasis><citetitle>Clostridium difficile</citetitle></emphasis> infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">66:</emphasis>e1–e48.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Ashraf H, Beltinger J, Alam NH, Bardhan PK, Faruque AS, Akter J, Salam MA, Gyr N.</emphasis> 2007. Evaluation of faecal occult blood test and lactoferrin latex agglutination test in screening hospitalized patients for diagnosing inflammatory and non-inflammatory diarrhoea in Dhaka, Bangladesh. <emphasis><citetitle>Digestion</citetitle></emphasis> <emphasis role="strong">76:</emphasis>256–261.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Kiska DL, Riddell SW.</emphasis> 2011. Counterpoint: should all stools be screened for Shiga toxin-producing <emphasis><citetitle>Escherichia coli</citetitle></emphasis>? <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>2394–2397.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Marcon MJ, Kiska DL, Riddell SW, Gilligan P.</emphasis> 2011. Point: should all stools be screened for Shiga toxin-producing <emphasis><citetitle>Escherichia coli</citetitle></emphasis>? <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>2390–2394.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Gould LH, Bopp C, Strockbine N, Atkinson R, Baselski V, Body B, Carey R, Crandall C, Hurd S, Kaplan R, Neill M, Shea S, Somsel P, Tobin-D’Angelo M, Griffin PM, Gerner-Smidt P, Centers for Disease Control and Prevention.</emphasis> 2009. Recommendations for diagnosis of Shiga toxin-producing <emphasis><citetitle>Escherichia coli</citetitle></emphasis> infections by clinical laboratories. <emphasis><citetitle>MMWR Recomm Rep</citetitle></emphasis> <emphasis role="strong">58</emphasis>(RR-12)<emphasis role="strong">:</emphasis>1–14.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">APHL STEC Work Group.</emphasis> 2012. Guidance for public health laboratories on the isolation and characterization of Shiga toxin-producing <emphasis><citetitle>Escherichia coli</citetitle></emphasis> (STEC) from clinical specimens. Association of Public Health Laboratories, Silver Spring, MD. <ulink url="https://www.aphl.org/AboutAPHL/publications/Documents/FS_2012April_Guidance-for-PHLs-Isolation-and-Characterization-of-Shiga-Toxin-Producing-Escherichia-coli-STEC-from-Clinical.pdf">https://www.aphl.org/AboutAPHL/publications/Documents/FS_2012April_Guidance-for-PHLs-Isolation-and-Characterization-of-Shiga-Toxin-Producing-Escherichia-coli-STEC-from-Clinical.pdf</ulink></para>
          </listitem>
          <listitem id="ch0035s0035s0001li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Rosin P, Niskanen T, Palm D, Struelens M, Takkinen J,</emphasis> Shiga toxin-producing Escherichia coli Experts of European Union Food- and Waterborne Diseases and Zoonoses Network. 2013. Laboratory preparedness for detection and monitoring of Shiga toxin 2-producing <emphasis><citetitle>Escherichia coli</citetitle></emphasis> O104:H4 in Europe and response to the 2011 outbreak. <emphasis><citetitle>Euro Surveill</citetitle></emphasis> <emphasis role="strong">18</emphasis>:20508.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Weinstein JW, Tallapragada S, Farrel P, Dembry LM.</emphasis> 1996. Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">34:</emphasis>210–212.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Singh K, Mangold KA, Wyant K, Schora DM, Voss B, Kaul KL, Hayden MK, Chundi V, Peterson LR.</emphasis> 2012. Rectal screening for <emphasis><citetitle>Klebsiella pneumoniae</citetitle></emphasis> carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>2596–2600.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Ginocchio CC, Chapin K, Smith JS, Aslanzadeh J, Snook J, Hill CS, Gaydos CA.</emphasis> 2012. Prevalence of <emphasis><citetitle>Trichomonas vaginalis</citetitle></emphasis> and coinfection with <emphasis><citetitle>Chlamydia trachomatis</citetitle></emphasis> and <emphasis><citetitle>Neisseria gonorrhoeae</citetitle></emphasis> in the United States as determined by the Aptima <emphasis><citetitle>Trichomonas vaginalis</citetitle></emphasis> nucleic acid amplification assay. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>2601–2608.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Centers for Disease Control and Prevention.</emphasis> 2021. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep <emphasis role="strong">70:</emphasis>1–187.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Uprety P, Cárdenas AM.</emphasis> 2019. Extragenital screening is essential for comprehensive detection of <emphasis><citetitle>Chlamydia trachomatis</citetitle></emphasis> and <emphasis><citetitle>Neisseria gonorrhoeae</citetitle></emphasis> in the pediatric population. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">57:</emphasis>e00335-19.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Van Der Pol B, Chernesky M, Gaydos CA, Hook EW III, Joseph AM, Christensen K, Arcenas R, Boutwell A, Wiesenfeld HC, Taylor SN, Mayer KH, Golden MR, Moncada J, Jang D, Schachter J, ExGen Study Group.</emphasis> 2022. Multicenter comparison of nucleic acid amplification tests for the diagnosis of rectal and oropharyngeal <emphasis><citetitle>Chlamydia trachomatis</citetitle></emphasis> and <emphasis><citetitle>Neisseria gonorrhoeae</citetitle></emphasis> infections. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">60:</emphasis>e01363-21.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Moncada J, Schachter J, Liska S, Shayevich C, Klausner JD.</emphasis> 2009. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of <emphasis><citetitle>Chlamydia trachomatis</citetitle></emphasis> and <emphasis><citetitle>Neisseria gonorrhoeae</citetitle></emphasis> by use of nucleic acid amplification tests. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>1657–1662.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0098" role="bibliographyEntry">
            <anchor id="ch0035s0035s0001a0006"/>
            <para>98.<emphasis role="strong">Shafer MA, Moncada J, Boyer CB, Betsinger K, Flinn SD, Schachter J.</emphasis> 2003. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect <emphasis><citetitle>Chlamydia trachomatis</citetitle></emphasis> and <emphasis><citetitle>Neisseria gonorrhoeae</citetitle></emphasis> by a nucleic acid amplification test. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">41:</emphasis>4395–4399.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Graver MA, Wade JJ.</emphasis> 2004. Survival of <emphasis><citetitle>Neisseria gonorrhoeae</citetitle></emphasis> isolates of different auxotypes in six commercial transport systems. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>4803–4804.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Gumede L, Radebe F, Nhlapo D, Maseko V, Kufa-Chakezha T, Kularatne R.</emphasis> 2017. Evaluation of the Copan eSwab<superscript>®</superscript>, a liquid-based microbiology transport system, for the preservation of <emphasis><citetitle>Neisseria gonorrhoeae</citetitle></emphasis> at different temperatures. <emphasis><citetitle>S Afr J Infect Dis</citetitle></emphasis> <emphasis role="strong">32:</emphasis>96–99.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Arbique JC, Forward KR, LeBlanc J.</emphasis> 2000. Evaluation of four commercial transport media for the survival of <emphasis><citetitle>Neisseria gonorrhoeae</citetitle></emphasis>. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">36:</emphasis>163–168.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">Srinivasan S, Fredricks DN.</emphasis> 2008. The human vaginal bacterial biota and bacterial vaginosis. <emphasis><citetitle>Interdiscip Perspect Infect Dis</citetitle></emphasis> <emphasis role="strong">2008:</emphasis>750479.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Nugent RP, Krohn MA, Hillier SL.</emphasis> 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">29:</emphasis>297–301.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Coleman JS, Gaydos CA.</emphasis> 2018. Molecular diagnosis of bacterial vaginosis: an update. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">56:</emphasis>e00342-18.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Committee on Obstetric Practice.</emphasis> 2019. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee opinion summary, number 782. <emphasis><citetitle>Obstet Gynecol</citetitle></emphasis> <emphasis role="strong">134:</emphasis>1.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Filkins L, Hauser JR, Robinson-Dunn B, Tibbetts R, Boyanton BL, Revell P.</emphasis> 2020. American Society for Microbiology provides 2020 guidelines for detection and identification of group B <emphasis><citetitle>Streptococcus</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">59:</emphasis>e01230-20.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Rosa-Fraile M, Spellerberg B.</emphasis> 2017. Reliable detection of group B <emphasis><citetitle>Streptococcus</citetitle></emphasis> in the clinical laboratory. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">55:</emphasis>2590–2598.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Desai H, Agrawal A.</emphasis> 2012. Pulmonary emergencies: pneumonia, acute respiratory distress syndrome, lung abscess, and empyema. <emphasis><citetitle>Med Clin North Am</citetitle></emphasis> <emphasis role="strong">96:</emphasis>1127–1148.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Morris AJ, Tanner DC, Reller LB.</emphasis> 1993. Rejection criteria for endotracheal aspirates from adults. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">31:</emphasis>1027–1029.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Morris AJ, Smith LK, Mirrett S, Reller LB.</emphasis> 1996. Cost and time savings following introduction of rejection criteria for clinical specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">34:</emphasis>355–357.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Wong LK, Barry AL, Horgan SM.</emphasis> 1982. Comparison of six different criteria for judging the acceptability of sputum specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">16:</emphasis>627–631.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Banu S, Hossain S, Uddin MK, Rahman MT, Khatun R, Zaman K, Quaiyum MA, van Leth F.</emphasis> 2012. Comparison of macroscopic and microscopic assessment of specimens collected for the diagnosis of tuberculosis. <emphasis><citetitle>Open Infect Dis J</citetitle></emphasis> <emphasis role="strong">6:</emphasis>1–4.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Webber DM, Wallace MA, Burnham CA, Anderson NW.</emphasis> 2020. Evaluation of the BioFire FilmArray Pneumonia panel for detection of viral and bacterial pathogens in lower respiratory tract specimens in the setting of a tertiary care academic medical center. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">58:</emphasis>e00343-20.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0114" role="bibliographyEntry">
            <para>114.<emphasis role="strong">Aucar JA, Bongera M, Phillips JO, Kamath R, Metzler MH.</emphasis> 2003. Quantitative tracheal lavage versus bronchoscopic protected specimen brush for the diagnosis of nosocomial pneumonia in mechanically ventilated patients. <emphasis><citetitle>Am J Surg</citetitle></emphasis> <emphasis role="strong">186:</emphasis>591–596.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0115" role="bibliographyEntry">
            <para>115.<emphasis role="strong">Miller MB, Gilligan PH.</emphasis> 2003. Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">41:</emphasis>4009–4015.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0116" role="bibliographyEntry">
            <para>116.<emphasis role="strong">Henry D, Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, Roe MH, Vandamme P, Speert D.</emphasis> 1999. Comparison of isolation media for recovery of <emphasis><citetitle>Burkholderia cepacia</citetitle></emphasis> complex from respiratory secretions of patients with cystic fibrosis. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">37:</emphasis>1004–1007.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0117" role="bibliographyEntry">
            <para>117.<emphasis role="strong">D’Souza HA, Baron EJ.</emphasis> 2005. BBL CHROMagar Staph aureus is superior to mannitol salt for detection of <emphasis><citetitle>Staphylococcus aureus</citetitle></emphasis> in complex mixed infections. <emphasis><citetitle>Am J Clin Pathol</citetitle></emphasis> <emphasis role="strong">123:</emphasis>806–808.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0118" role="bibliographyEntry">
            <para>118.<emphasis role="strong">Esther CR Jr, Hoberman S, Fine J, Allen S, Culbreath K, Rodino K, Kerr A, Gilligan P.</emphasis> 2011. Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>1421–1425.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0119" role="bibliographyEntry">
            <para>119.<emphasis role="strong">Hayes JF, Baddley JW.</emphasis> 2019. Respiratory infections. <emphasis><citetitle>In</citetitle></emphasis> Spec A, Escota GV, Chrisler C, Davies B (ed), <emphasis><citetitle>Comprehensive Review of Infectious Diseases</citetitle></emphasis>. Elsevier, Amsterdam, The Netherlands.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0120" role="bibliographyEntry">
            <para>120.<emphasis role="strong">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C, Infectious Diseases Society of America.</emphasis> 2012. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">55:</emphasis>e86–e102. (Correction, 58:1496.)</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0121" role="bibliographyEntry">
            <para>121.<emphasis role="strong">Durant TJS, Merwede J, Reynolds J, Peaper DR.</emphasis> 2019. Optimization of turnaround time for group A streptococcus PCR. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">57:</emphasis>e00619-19.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0122" role="bibliographyEntry">
            <para>122.<emphasis role="strong">Amess JA, O’Neill W, Giollariabhaigh CN, Dytrych JK.</emphasis> 2007. A six-month audit of the isolation of <emphasis><citetitle>Fusobacterium necrophorum</citetitle></emphasis> from patients with sore throat in a district general hospital. <emphasis><citetitle>Br J Biomed Sci</citetitle></emphasis> <emphasis role="strong">64:</emphasis>63–65.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0123" role="bibliographyEntry">
            <para>123.<emphasis role="strong">Williams MM, Taylor TH</emphasis> Jr<emphasis role="strong">, Warshauer DM, Martin MD, Valley AM, Tondella ML.</emphasis> 2015. Harmonization of <emphasis><citetitle>Bordetella pertussis</citetitle></emphasis> real-time PCR diagnostics in the United States in 2012. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">53:</emphasis>118–123.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0124" role="bibliographyEntry">
            <para>124.<emphasis role="strong">Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV, Advisory Committee on Immunization Practices (ACIP).</emphasis> 2006. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). <emphasis><citetitle>MMWR Recomm Rep</citetitle></emphasis> <emphasis role="strong">55</emphasis>(RR-3)<emphasis role="strong">:</emphasis>1–34.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0125" role="bibliographyEntry">
            <para>125.<emphasis role="strong">Brook I.</emphasis> 2011. Microbiology of sinusitis. <emphasis><citetitle>Proc Am Thorac Soc</citetitle></emphasis> <emphasis role="strong">8:</emphasis>90–100.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0126" role="bibliographyEntry">
            <para>126.<emphasis role="strong">Orlandi RR.</emphasis> 2004. Biopsy and specimen collection in chronic rhinosinusitis. <emphasis><citetitle>Ann Otol Rhinol Laryngol Suppl</citetitle></emphasis> <emphasis role="strong">193</emphasis>(Suppl)<emphasis role="strong">:</emphasis>24–26.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0127" role="bibliographyEntry">
            <para>127.<emphasis role="strong">Mackay IM, Harnett G, Jeoffreys N, Bastian I, Sriprakash KS, Siebert D, Sloots TP.</emphasis> 2006. Detection and discrimination of herpes simplex viruses, <emphasis><citetitle>Haemophilus ducreyi</citetitle>, <citetitle>Treponema pallidum</citetitle></emphasis>, and <emphasis><citetitle>Calymmatobacterium</citetitle></emphasis> (<emphasis><citetitle>Klebsiella</citetitle></emphasis>) <emphasis><citetitle>granulomatis</citetitle></emphasis> from genital ulcers. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">42:</emphasis>1431–1438.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0128" role="bibliographyEntry">
            <para>128.<emphasis role="strong">Wolcott R, Costerton JW, Raoult D, Cutler SJ.</emphasis> 2013. The polymicrobial nature of biofilm infection. <emphasis><citetitle>Clin Microbiol Infect</citetitle></emphasis> <emphasis role="strong">19:</emphasis>107–112.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0129" role="bibliographyEntry">
            <para>129.<emphasis role="strong">Uppal SK, Ram S, Kwatra B, Garg S, Gupta R.</emphasis> 2007. Comparative evaluation of surface swab and quantitative full thickness wound biopsy culture in burn patients. <emphasis><citetitle>Burns</citetitle></emphasis> <emphasis role="strong">33:</emphasis>460–463.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0130" role="bibliographyEntry">
            <para>130.<emphasis role="strong">Kallstrom G.</emphasis> 2014. Are quantitative bacterial wound cultures useful? <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>2753–2756.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0131" role="bibliographyEntry">
            <para>131.<emphasis role="strong">Ker CC, Hung CC, Huang SY, Chen MY, Hsieh SM, Lin CC, Chang SC, Luh KT.</emphasis> 2002. Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodeficiency syndrome. <emphasis><citetitle>J Microbiol Immunol Infect</citetitle></emphasis> <emphasis role="strong">35:</emphasis>89–93.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0132" role="bibliographyEntry">
            <para>132.<emphasis role="strong">Volk EE, Miller ML, Kirkley BA, Washington JA.</emphasis> 1998. The diagnostic usefulness of bone marrow cultures in patients with fever of unknown origin. <emphasis><citetitle>Am J Clin Pathol</citetitle></emphasis> <emphasis role="strong">110:</emphasis>150–153.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0133" role="bibliographyEntry">
            <para>133.<emphasis role="strong">Stevens DL, Bryant AE.</emphasis> 2017. Necrotizing soft-tissue infections. <emphasis><citetitle>N Engl J Med</citetitle></emphasis> <emphasis role="strong">377:</emphasis>2253–2265.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0134" role="bibliographyEntry">
            <para>134.<emphasis role="strong">Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC.</emphasis> 2014. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">59:</emphasis>e10–e52. (Erratum, <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> 60:1448).</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0135" role="bibliographyEntry">
            <para>135.<emphasis role="strong">Goldgeier MH.</emphasis> 1983. The microbial evaluation of acute cellulitis. <emphasis><citetitle>Cutis</citetitle></emphasis> <emphasis role="strong">31:</emphasis>649–650, 653–654, 656.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0136" role="bibliographyEntry">
            <anchor id="ch0035s0035s0001a0007"/>
            <para>136.<emphasis role="strong">Bekeris LG, Jones BA, Walsh MK, Wagar EA.</emphasis> 2008. Urine culture contamination: a College of American Pathologists Q-Probes study of 127 laboratories. <emphasis><citetitle>Arch Pathol Lab Med</citetitle></emphasis> <emphasis role="strong">132:</emphasis>913–917.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0137" role="bibliographyEntry">
            <para>137.<emphasis role="strong">Chakraborti C, Le C, Yanofsky A.</emphasis> 2010. Sensitivity of superficial cultures in lower extremity wounds. <emphasis><citetitle>J Hosp Med</citetitle></emphasis> <emphasis role="strong">5:</emphasis>415–420.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0138" role="bibliographyEntry">
            <para>138.<emphasis role="strong">Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E, Infectious Diseases Society of America.</emphasis> 2012. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">54:</emphasis>e132–e173.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0139" role="bibliographyEntry">
            <para>139.<emphasis role="strong">Matkoski C, Sharp SE, Kiska DL.</emphasis> 2006. Evaluation of the Q score and Q234 systems for cost-effective and clinically relevant interpretation of wound cultures. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">44:</emphasis>1869–1872.</para>
          </listitem>
          <listitem id="ch0035s0035s0001li0140" role="bibliographyEntry">
            <para>140.<emphasis role="strong">Brecher SM, Novak-Weekley SM, Nagy E.</emphasis> 2013. Laboratory diagnosis of <emphasis><citetitle>Clostridium difficile</citetitle></emphasis> infections: there is light at the end of the colon. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">57:</emphasis>1175–1181.</para>
          </listitem>
        </itemizedlist>
        <orderedlist role="notesList">
          <listitem role="noteEntry">
            <para><anchor id="ch0035s0035s0001a0008"/><link linkend="ch0035s0001a0002">*</link>This chapter contains information presented by Ellen Jo Baron in <ulink url="ch0034#ch0034s0001">chapter 18</ulink> of the 11th edition of this <emphasis>Manual</emphasis>.</para>
          </listitem>
        </orderedlist>
      </sect2>
    </sect1>
  </chapter>
